Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
52000,,1866554,CHEMBL916945,Antistaphylococcal activity against quinolone and methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147106,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634914,>=,1,1,>=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
52001,,1866846,CHEMBL915679,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 750 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,75.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,75.0
52002,,1866893,CHEMBL915684,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 1000 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,117.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,117.0
52003,,1866894,CHEMBL915683,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 937.5 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,104.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,104.0
52004,,1866895,CHEMBL915682,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 875 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,94.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,94.0
52005,,1866896,CHEMBL915681,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 843.5 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,86.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,86.0
52006,,1866898,CHEMBL915680,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 812.5 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,83.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,83.0
52007,,1866918,CHEMBL915672,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 1000 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,114.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,114.0
52008,,1866920,CHEMBL915671,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 875 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,97.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,97.0
52009,,1866940,CHEMBL915670,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 843.5 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,89.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,89.0
52010,,1866941,CHEMBL915669,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 812.5 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,82.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,82.0
52011,,1866943,CHEMBL915668,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 750 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,79.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,79.0
52012,,1866944,CHEMBL915667,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 500 mg,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,=,1,0,=,fAUC/MIC,,55.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,55.0
52013,,1867237,CHEMBL914132,Susceptibility of penicillin-resistant Streptococcus pneumoniae 335 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52014,,1867242,CHEMBL914133,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52015,,1867249,CHEMBL914134,Effect on 0.5 ug/ml sitofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52016,,1867254,CHEMBL914135,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52017,,1867258,CHEMBL915624,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
52018,,1867263,CHEMBL915625,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52019,,1867268,CHEMBL915626,Susceptibility of penicillin-resistant Streptococcus pneumoniae 334 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52020,,1867272,CHEMBL914661,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52021,,1867276,CHEMBL915629,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52022,,1867280,CHEMBL915630,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52023,,1867284,CHEMBL915631,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52024,,1867288,CHEMBL915632,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52025,,1867293,CHEMBL915633,Susceptibility of penicillin-resistant Streptococcus pneumoniae 216 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52026,,1867297,CHEMBL915634,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52027,,1867303,CHEMBL915635,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52028,,1867307,CHEMBL915636,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
52029,,1867311,CHEMBL915637,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52030,,1867319,CHEMBL915638,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52031,,1867328,CHEMBL915639,Susceptibility of penicillin-resistant Streptococcus pneumoniae 217 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52032,,1867335,CHEMBL915640,Effect on 0.03 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52033,,1867340,CHEMBL915641,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52034,,1867344,CHEMBL915642,Effect on 0.5 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52035,,1867349,CHEMBL915643,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52036,,1867356,CHEMBL915033,Effect on 8 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52037,,1867362,CHEMBL915034,Susceptibility of penicillin-resistant Streptococcus pneumoniae 218 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52038,,1867372,CHEMBL915035,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52039,,1867383,CHEMBL915036,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52040,,1867388,CHEMBL914130,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52041,,1867392,CHEMBL915037,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52042,,1867397,CHEMBL915038,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52043,,1867479,CHEMBL914131,Susceptibility of methicillin-sensitive/resistant Staphylococcus aureus single-step mutant by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
52044,,1867493,CHEMBL915039,Susceptibility of vancomycin-resistant Enterococcus species single-step mutant by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,16.0
52045,,1867514,CHEMBL915040,Susceptibility of drug-selected vancomycin-resistant Enterococcus species mutant by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634752,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,256.0
52046,,1867988,CHEMBL918875,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
52047,,1867989,CHEMBL918875,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
52048,,1867998,CHEMBL919814,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
52049,,1867999,CHEMBL919814,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
52050,,1868008,CHEMBL919815,Antibacterial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52051,,1868009,CHEMBL919815,Antibacterial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52052,,1868024,CHEMBL919816,Antibacterial activity against Streptococcus viridans after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,ug ml-1,UO_0000274,1.0
52053,,1868025,CHEMBL919816,Antibacterial activity against Streptococcus viridans after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,ug ml-1,UO_0000274,1.0
52054,,1868044,CHEMBL919818,Antibacterial activity against Acinetobacter baumannii after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,0.25
52055,,1868045,CHEMBL919818,Antibacterial activity against Acinetobacter baumannii after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,8.0
52056,,1868055,CHEMBL919819,Antibacterial activity against Enterobacter sp.,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,MIC50,ug ml-1,UO_0000274,0.03
52057,,1868056,CHEMBL919819,Antibacterial activity against Enterobacter sp.,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,MIC90,ug ml-1,UO_0000274,0.5
52058,,1868078,CHEMBL919820,Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.03
52059,,1868079,CHEMBL919820,Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.03
52060,,1868098,CHEMBL919821,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC50,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.25
52061,,1868099,CHEMBL919821,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,2.0
52062,,1868141,CHEMBL919269,Antibacterial activity against Enterococcus faecalis,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,16.0
52063,,1868142,CHEMBL919269,Antibacterial activity against Enterococcus faecalis,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
52064,,1868153,CHEMBL919270,Antibacterial activity against Enterococcus faecium,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,16.0
52065,,1868154,CHEMBL919270,Antibacterial activity against Enterococcus faecium,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
52066,,1868161,CHEMBL919271,Antibacterial activity against Streptococcus pyogenes,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
52067,,1868162,CHEMBL919271,Antibacterial activity against Streptococcus pyogenes,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,1.0
52068,,1868164,CHEMBL919272,Antibacterial activity against Legionella pneumophila after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC,ug ml-1,UO_0000274,0.015
52069,,1868223,CHEMBL919273,Antibacterial activity against Mycoplasma pneumoniae after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.5
52070,,1868234,CHEMBL919808,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,0.5
52071,,1868235,CHEMBL919808,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,8.0
52072,,1868242,CHEMBL919274,Antibacterial activity against Haemophilus influenzae after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
52073,,1868243,CHEMBL919274,Antibacterial activity against Haemophilus influenzae after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.03
52074,,1868250,CHEMBL919809,Antibacterial activity against Moraxella catarrhalis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.03
52075,,1868251,CHEMBL919809,Antibacterial activity against Moraxella catarrhalis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.06
52076,,1868267,CHEMBL919275,Antibacterial activity against Neisseria meningitidis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,<=,1,1,<=,MIC50,ug.mL-1,0.12,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.12
52077,,1868268,CHEMBL919275,Antibacterial activity against Neisseria meningitidis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634851,<=,1,1,<=,MIC90,ug.mL-1,0.12,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.12
52078,,1868390,CHEMBL920714,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634670,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52079,,1868391,CHEMBL920714,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634670,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52080,,1868419,CHEMBL920715,Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent susceptible isolates,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,634670,=,1,0,=,Activity,%,98.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.8
52081,,1868433,CHEMBL917518,Antibacterial activity against Salmonella enterica serovar Enteritidis,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634909,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC50,ug ml-1,UO_0000274,0.03
52082,,1868434,CHEMBL917518,Antibacterial activity against Salmonella enterica serovar Enteritidis,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634909,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC90,ug ml-1,UO_0000274,0.06
52083,,1868441,CHEMBL917519,Antimicrobial activity against Bacteroides distasonis,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634909,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC90,ug ml-1,UO_0000274,32.0
52084,,1868442,CHEMBL917519,Antimicrobial activity against Bacteroides distasonis,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634909,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC50,ug ml-1,UO_0000274,8.0
52085,,1868456,CHEMBL920716,Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,634670,=,1,0,=,Activity,%,0.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.4
52086,,1869725,CHEMBL914164,Peak free concentration at 500 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,0,=,Activity,ug ml-1,4.1,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,4.1
52087,,1869726,CHEMBL914165,Peak free concentration at 750 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,0,=,Activity,ug ml-1,6.13,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,6.13
52088,,1869727,CHEMBL914166,Peak free concentration at 812.5 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,0,=,Activity,ug ml-1,6.78,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,6.78
52089,,1869728,CHEMBL914167,Peak free concentration at 875 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,0,=,Activity,ug ml-1,7.19,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,7.19
52090,,1869729,CHEMBL914168,Peak free concentration at 1000 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,0,=,Activity,ug ml-1,8.75,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,8.75
52091,,1869770,CHEMBL914184,Peak free concentration at 843.5 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,0,=,Activity,ug ml-1,7.09,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,7.09
52092,,1869865,CHEMBL914178,Half life at 500 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,634948,=,1,1,=,T1/2,hr,8.01,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,8.01
52093,,1869867,CHEMBL914179,Half life at 750 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,634948,=,1,1,=,T1/2,hr,7.52,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,7.52
52094,,1869873,CHEMBL914180,Half life at 812.5 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,634948,=,1,1,=,T1/2,hr,7.06,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,7.06
52095,,1869878,CHEMBL914181,Half life at 875 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,634948,=,1,1,=,T1/2,hr,8.02,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,8.02
52096,,1869896,CHEMBL914182,Half life at 1000 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,634948,=,1,1,=,T1/2,hr,7.85,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,7.85
52097,,1869983,CHEMBL915103,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 55 after 24 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52098,,1869984,CHEMBL914155,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y and gyrA S81Y mutation at fAUC/MIC of 55 after 48 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
52099,,1869985,CHEMBL914154,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation at fAUC/MIC of 79 after 24 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.5
52100,,1869986,CHEMBL915104,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation and gyrA S81Y mutation at fAUC/MIC of 79 after 48 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
52101,,1869987,CHEMBL915105,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation at fAUC/MIC of 82 after 24 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.5
52102,,1869988,CHEMBL915106,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation and gyrA E85G mutation at fAUC/MIC of 82 after 48 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
52103,,1869989,CHEMBL915107,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 89 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52104,,1869990,CHEMBL915108,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 97 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52105,,1869991,CHEMBL916607,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 114 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52106,,1869992,CHEMBL916608,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S81Y mutation at fAUC/MIC of 75 after 24 to 96 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
52107,,1869993,CHEMBL916609,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation at fAUC/MIC of 83 after 96 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,2.0
52108,,1869994,CHEMBL916610,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 83 after 24 to 72 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52109,,1869995,CHEMBL916611,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 86 after 24 to 72 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52110,,1869996,CHEMBL916612,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S81Y mutation at fAUC/MIC of 86 after 96 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
52111,,1869997,CHEMBL916613,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 94 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52112,,1869998,CHEMBL916614,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 104 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52113,,1869999,CHEMBL916615,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 117 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
52114,,1870016,CHEMBL914153,Susceptibility of Streptococcus pneumoniae ATCC 49619 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.025
52115,,1870019,CHEMBL914732,Susceptibility of Streptococcus pneumoniae BSP-2443 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634948,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.025
52116,,1870029,CHEMBL914186,Half life at 843.5 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,634948,=,1,1,=,T1/2,hr,6.98,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,6.98
52117,Not Active,1870037,CHEMBL916090,Effect on efflux-mediatated resistance of Staphylococcus aureus ATCC 49619 mutant,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,634948,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
52118,,1896788,CHEMBL887468,Antibacterial activity against Staphylococcus aureus UC76,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144619,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,641780,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52119,,1896811,CHEMBL887469,Antibacterial activity against Staphylococcus aureus SA2552,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144619,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,641780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52120,,1896834,CHEMBL887470,Antibacterial activity against Streptococcus pneumoniae SV1,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144619,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,641780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52121,,1896857,CHEMBL886336,Antibacterial activity against fluoroquinolone resistance Streptococcus pneumoniae SP3765,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144619,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,641780,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52122,,1896880,CHEMBL886337,Antibacterial activity against Haemophilus influenzae HI3542,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144619,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,641780,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
52123,,1896903,CHEMBL886339,Antibacterial activity against Moraxella catarrhalis BC-3531,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144619,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,641780,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.06
52124,,1932589,CHEMBL892637,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52125,,1932605,CHEMBL892638,Antibacterial activity against Staphylococcus aureus ATCC 6538p after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52126,,1932621,CHEMBL892639,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52127,,1932637,CHEMBL892640,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52128,,1932653,CHEMBL892641,Antibacterial activity against Staphylococcus epidermidis ATCC 14940 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
52129,,1932669,CHEMBL892642,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
52130,,1932685,CHEMBL892643,Antibacterial activity against Bacillus subtilis ATCC 6051 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.5
52131,,1932701,CHEMBL892644,Antibacterial activity against Enterococcus faecalis NCTC 6013 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
52132,,1932717,CHEMBL892645,Antibacterial activity against Serratia marcescens PTCC 1111 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.5
52133,,1932733,CHEMBL892646,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
52134,,1932749,CHEMBL892647,Antibacterial activity against Escherichia coli NCTC 12900 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
52135,,1932765,CHEMBL892648,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
52136,,1932781,CHEMBL892649,Antibacterial activity against Salmonella typhi ATCC 19430 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.03
52137,,1932797,CHEMBL892650,Antibacterial activity against Shigella flexneri NCTC 8516 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,0.03
52138,,1932813,CHEMBL892651,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1147210,Eur J Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,649658,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
52139,,1955402,CHEMBL891393,Antibacterial activity against quinoline-susceptible methicillin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52140,,1955417,CHEMBL891394,Antibacterial activity against quinoline-intermediate methicillin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
52141,,1955432,CHEMBL891395,Antibacterial activity against quinoline-resistant methicillin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
52142,,1955447,CHEMBL891396,Antibacterial activity against Enterococcus faecalis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
52143,,1955462,CHEMBL891397,Antibacterial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52144,,1955477,CHEMBL891398,Antibacterial activity against Moraxella catarrhalis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.063
52145,,1955492,CHEMBL891399,Antibacterial activity against Haemophilus influenzae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
52146,,1955507,CHEMBL891400,Antibacterial activity against Escherichia coli without AcrAB efflux system by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
52147,,1955522,CHEMBL891401,Antibacterial activity against Escherichia coli with AcrAB efflux system by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
52148,,1955537,CHEMBL891402,Antibacterial activity against Pseudomonas aeruginosa by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647139,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
52149,,1970805,CHEMBL896705,Antibacterial activity against Staphylococcus aureus by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1149559,Bioorg Med Chem Lett,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,658478,=,1,1,=,IZ,mm,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,32.0
52150,,1986358,CHEMBL898677,Antibacterial activity against Staphylococcus aureus 26003 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137480,Bioorg Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,662750,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
52151,,1986406,CHEMBL898678,Antibacterial activity against Staphylococcus epidermidis 26069 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137480,Bioorg Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,662750,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.78
52152,,1986454,CHEMBL898679,Antibacterial activity against Streptococcus pneumoniae 31002 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137480,Bioorg Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,662750,=,1,1,=,MIC,ug.mL-1,0.195,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.195
52153,,1986502,CHEMBL898680,Antibacterial activity against Shigella boydii 51313 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137480,Bioorg Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,662750,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,MIC,ug ml-1,UO_0000274,0.098
52154,,1986550,CHEMBL898681,Antibacterial activity against Klebsiella pneumoniae 46101 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137480,Bioorg Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,662750,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.098
52155,,1986598,CHEMBL898682,Antibacterial activity against Salmonella citrobacter 48107 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137480,Bioorg Med Chem,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,662750,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,ug ml-1,UO_0000274,0.098
52156,,2124462,CHEMBL953034,Inhibition of Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as inhibition of pBR322 DNA supercoiling,B,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704413,=,1,1,=,IC50,ug.mL-1,7.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,IC50,ug ml-1,UO_0000274,7.0
52157,Not Determined,2124488,CHEMBL953036,Antibacterial activity against Mycobacterium leprae at 5 ug/mL after 11 to 18 days,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,704413,,1,0,,Activity,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,,,
52158,Not Determined,2124505,CHEMBL938433,Antibacterial activity in Mycobacterium leprae infected mouse foot-pad model assessed as parasite killing after 9 months,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,704413,,1,0,,Activity,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,,,
52159,,2126518,CHEMBL935009,Antimicrobial activity against Streptococcus pneumoniae WB4 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143816,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702323,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,1.0
52160,,2127016,CHEMBL936772,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae FH,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.5
52161,,2127020,CHEMBL936773,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae Mac,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
52162,,2127024,CHEMBL936774,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae M129,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
52163,,2127028,CHEMBL936775,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2063G mutant isolate 1,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
52164,,2127032,CHEMBL935914,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2063G mutant isolate 6,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.5
52165,,2127036,CHEMBL935916,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 4,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
52166,,2127040,CHEMBL935915,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 2,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703071,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
52167,,2127235,CHEMBL936102,Antimicrobial activity against extended-spectrum-beta-lactamase producing Escherichia coli isolates,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703086,>=,1,1,>=,MIC50,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,32.0
52168,,2127236,CHEMBL936102,Antimicrobial activity against extended-spectrum-beta-lactamase producing Escherichia coli isolates,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703086,>=,1,1,>=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
52169,,2127252,CHEMBL936103,Antimicrobial activity against extended-spectrum-beta-lactamase producing Escherichia coli assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,703086,=,1,0,=,Activity,%,8.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,8.6
52170,,2127262,CHEMBL936104,Antimicrobial activity against extended-spectrum-beta-lactamase producing Klebsiella pneumoniae isolates,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703086,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,2.0
52171,,2127263,CHEMBL936104,Antimicrobial activity against extended-spectrum-beta-lactamase producing Klebsiella pneumoniae isolates,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703086,>=,1,1,>=,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
52172,,2127279,CHEMBL936101,Antimicrobial activity against extended-spectrum-beta-lactamase producing Klebsiella pneumoniae assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,703086,=,1,0,=,Activity,%,48.2,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,48.2
52173,,2127289,CHEMBL936105,Antimicrobial activity against extended-spectrum-beta-lactamase producing Proteus mirabilis isolates,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703086,>=,1,1,>=,MIC50,ug.mL-1,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,32.0
52174,,2127290,CHEMBL936105,Antimicrobial activity against extended-spectrum-beta-lactamase producing Proteus mirabilis isolates,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703086,>=,1,1,>=,MIC90,ug.mL-1,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,32.0
52175,,2127306,CHEMBL936106,Antimicrobial activity against extended-spectrum-beta-lactamase producing Proteus mirabilis assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143836,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,703086,=,1,0,=,Activity,%,12.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,12.5
52176,,2127691,CHEMBL938380,Antibacterial activity against TEM92 ESBL-producing Acinetobacter baumannii by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144462,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703564,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
52177,,2127743,CHEMBL938381,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
52178,,2127744,CHEMBL938381,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,16.0
52179,,2127746,CHEMBL938382,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
52180,,2127749,CHEMBL938383,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
52181,,2127750,CHEMBL938383,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,4.0
52182,,2127752,CHEMBL938384,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
52183,,2127755,CHEMBL951356,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae1960 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
52184,,2127756,CHEMBL951356,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae1960 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,64.0
52185,,2127758,CHEMBL951357,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1960 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
52186,,2127761,CHEMBL951358,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
52187,,2127762,CHEMBL951358,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,32.0
52188,,2127764,CHEMBL951359,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
52189,,2127767,CHEMBL951360,Antimicrobial activity against Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
52190,,2127768,CHEMBL951360,Antimicrobial activity against Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.015
52191,,2127770,CHEMBL951361,Antimicrobial activity against Escherichia coli DH10B GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52192,,2127773,CHEMBL951362,Antimicrobial activity against Escherichia coli DH10B/pACYC184 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
52193,,2127774,CHEMBL951362,Antimicrobial activity against Escherichia coli DH10B/pACYC184 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.015
52194,,2127776,CHEMBL952170,Antimicrobial activity against Escherichia coli DH10B/pACYC184 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52195,,2127779,CHEMBL952171,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
52196,,2127780,CHEMBL952171,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,2.0
52197,,2127782,CHEMBL952172,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
52198,,2127785,CHEMBL952173,Antimicrobial activity against Escherichia coli J53 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52199,,2127786,CHEMBL952173,Antimicrobial activity against Escherichia coli J53 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.06
52200,,2127788,CHEMBL952174,Antimicrobial activity against Escherichia coli J53 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
52201,,2127791,CHEMBL952175,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
52202,,2127792,CHEMBL952175,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,4.0
52203,,2127794,CHEMBL952176,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
52204,,2127797,CHEMBL952177,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
52205,,2127798,CHEMBL952177,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,4.0
52206,,2127800,CHEMBL952178,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
52207,,2127803,CHEMBL952179,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
52208,,2127804,CHEMBL952179,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,4.0
52209,,2127806,CHEMBL952180,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
52210,,2127809,CHEMBL952181,Antimicrobial activity against Escherichia coli J53/p1132 negative expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52211,,2127810,CHEMBL952181,Antimicrobial activity against Escherichia coli J53/p1132 negative expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.06
52212,,2127812,CHEMBL952182,Antimicrobial activity against Escherichia coli J53/p1132 negative GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
52213,,2127815,CHEMBL952183,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
52214,,2127816,CHEMBL952183,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,8.0
52215,,2127818,CHEMBL952184,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
52216,,2127821,CHEMBL952185,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
52217,,2127822,CHEMBL952185,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,0,=,MPC,ug ml-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,128.0
52218,,2127824,CHEMBL952186,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703773,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
52219,,2127832,CHEMBL935853,Antibacterial activity against wild type Staphylococcus aureus RN4220,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52220,,2127854,CHEMBL935854,Antibacterial activity against Staphylococcus aureus RN4220 with rplC D159Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52221,,2127859,CHEMBL935855,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G155R mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52222,,2127864,CHEMBL935856,Antibacterial activity against Staphylococcus aureus RN4220 with rplC S158L mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52223,,2127869,CHEMBL935857,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52224,,2127874,CHEMBL935858,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D and D159Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52225,,2127879,CHEMBL935859,Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D and G155R mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52226,,2127884,CHEMBL935860,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y and G144R mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52227,,2127889,CHEMBL935861,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y and G155R mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52228,,2127894,CHEMBL935862,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y, G155R and H134N mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52229,,2127899,CHEMBL935863,"Antibacterial activity against Staphylococcus aureus RN4220 with rplC G152D, D159Y, G155R and A150T mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52230,,2127903,CHEMBL935864,"Antibacterial activity against Staphylococcus aureus 2A1-1 with rplC G152D, D159Y and unmapped mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52231,,2127907,CHEMBL935865,"Antibacterial activity against Staphylococcus aureus 2A1-7 with rplC G152D, D159Y and unmapped mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52232,,2127911,CHEMBL935866,"Antibacterial activity against Staphylococcus aureus 2A1-8 with rplC G152D, D159Y and unmapped mutation",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52233,,2127915,CHEMBL935867,Antibacterial activity against Staphylococcus aureus 2A1-1 fast1 with rplC D159Y and unmapped mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52234,,2127919,CHEMBL935868,Antibacterial activity against Staphylococcus aureus 2A1-1 fast2 with rplC D159Y and unmapped mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52235,,2127923,CHEMBL935869,Antibacterial activity against Staphylococcus aureus 2A1-7 fast1 with rplC D159Y and unmapped mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52236,,2127927,CHEMBL935870,Antibacterial activity against Staphylococcus aureus 2A1-7 fast2 with rplC D159Y and unmapped mutation,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1144468,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703780,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52237,,2155478,CHEMBL921598,Antibacterial activity against methicillin-susceptible Staphylococcus aureus FDA 209P by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52238,,2155484,CHEMBL921599,Antibacterial activity against methicillin-susceptible Staphylococcus aureus Smith by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52239,,2155490,CHEMBL921600,Antibacterial activity against methicillin-resistant Staphylococcus aureus KT0116 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
52240,,2155496,CHEMBL921601,Antibacterial activity against methicillin-resistant Staphylococcus aureus KMP9 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
52241,,2155502,CHEMBL921602,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
52242,,2155508,CHEMBL927076,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52243,,2155514,CHEMBL927077,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae KT2524 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52244,,2155519,CHEMBL927078,Antibacterial activity against Streptococcus pyogenes ATCC 12344 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
52245,,2155525,CHEMBL927079,Antibacterial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
52246,,2155531,CHEMBL927080,Antibacterial activity against vancomycin-susceptible Enterococcus faecium ATCC 19434 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
52247,,2155537,CHEMBL927081,Antibacterial activity against vancomycin-resistant Enterococcus faecium KU1778 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
52248,,2155543,CHEMBL927082,Antibacterial activity against Moraxella catarrhalis K1209 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.063
52249,,2155549,CHEMBL927083,Antibacterial activity against Haemophilus influenzae TH13 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.032
52250,,2155569,CHEMBL927084,Antibacterial activity against Staphylococcus saccharolyticus GAI 5520 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
52251,,2155574,CHEMBL934791,Antibacterial activity against Streptococcus intermedius GAI 7416 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.5
52252,,2155579,CHEMBL934792,Antibacterial activity against Atopobium parvulum GAI 5542 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
52253,,2155584,CHEMBL934793,Antibacterial activity against Peptostreptococcus asaccharolyticus GAI 5534 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC,ug ml-1,UO_0000274,2.0
52254,,2155589,CHEMBL934794,Antibacterial activity against Peptostreptococcus anaerobius GAI 5506 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,0.125
52255,,2155594,CHEMBL934795,Antibacterial activity against Peptostreptococcus magnus GAI 5528 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC,ug ml-1,UO_0000274,0.125
52256,,2155599,CHEMBL934796,Antibacterial activity against Clostridium perfringens GAI 5526 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,ug ml-1,UO_0000274,0.25
52257,,2155604,CHEMBL934797,Antibacterial activity against Propionibacterium acnes GAI 5568 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC,ug ml-1,UO_0000274,0.25
52258,,2155609,CHEMBL934798,Antibacterial activity against Propionibacterium granulosum GAI 7414 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
52259,,2155614,CHEMBL934799,Antibacterial activity against Mycoplasma pneumoniae FH Liu by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.125
52260,,2155618,CHEMBL934800,Antibacterial activity against Mycoplasma pneumoniae Mac by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,695994,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.063
52261,,2155634,CHEMBL934801,Antibacterial activity against methicillin-susceptible Staphylococcus aureus Smith in mouse dosed iv 1 hr after infection,F,BAO_0003036,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,695994,=,1,1,=,ED50,mg.kg-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,0.78
52262,,2155639,CHEMBL934802,Antibacterial activity against methicillin-resistant Staphylococcus aureus KT0116 in mouse dosed iv 1 hr after infection,F,BAO_0003036,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,695994,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,100.0
52263,,2155644,CHEMBL934803,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 in mouse dosed iv 1 hr after infection,F,BAO_0003036,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,695994,=,1,1,=,ED50,mg.kg-1,24.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,24.7
52264,,2155649,CHEMBL922702,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae KT2524 in mouse dosed iv 1 hr after infection,F,BAO_0003036,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1142399,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,695994,>,1,1,>,ED50,mg.kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,100.0
52265,,2289123,CHEMBL998963,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52266,,2289151,CHEMBL998964,Antimicrobial activity against Escherichia coli ATCC 25922 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.025
52267,,2289178,CHEMBL998965,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
52268,,2289180,CHEMBL998966,Antimicrobial activity against Staphylococcus aureus isolate 1 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52269,,2289183,CHEMBL998967,Antimicrobial activity against Staphylococcus aureus isolate 2 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52270,,2289186,CHEMBL998968,Antimicrobial activity against Staphylococcus aureus isolate 3 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52271,,2289189,CHEMBL998969,Antimicrobial activity against Staphylococcus aureus isolate 4 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52272,,2289192,CHEMBL998970,Antimicrobial activity against Staphylococcus aureus isolate 5 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52273,,2289194,CHEMBL998971,Antimicrobial activity against Staphylococcus aureus isolate 6 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52274,,2289197,CHEMBL995424,Antimicrobial activity against Staphylococcus aureus isolate 7 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52275,,2289200,CHEMBL995425,Antimicrobial activity against Staphylococcus aureus isolate 8 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52276,,2289203,CHEMBL995426,Antimicrobial activity against Staphylococcus aureus isolate 9 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52277,,2289206,CHEMBL995427,Antimicrobial activity against Staphylococcus aureus isolate 10 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52278,,2289210,CHEMBL995428,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
52279,,2289215,CHEMBL995429,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
52280,,2289220,CHEMBL995430,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 3 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
52281,,2289225,CHEMBL995431,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 4 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
52282,,2289230,CHEMBL995432,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 5 after 16 to 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137674,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784511,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
52283,,2300266,CHEMBL949924,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU4A1 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52284,,2300267,CHEMBL949925,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU73 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
52285,,2300268,CHEMBL949926,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PUA1 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
52286,,2300269,CHEMBL949927,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PUA6 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
52287,,2300270,CHEMBL949928,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU86 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.125
52288,,2300271,CHEMBL949929,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PUA7 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
52289,,2300272,CHEMBL949930,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU78 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.125
52290,,2300273,CHEMBL950888,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU4A22 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52291,,2300274,CHEMBL950889,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate FW-F1 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52292,,2300275,CHEMBL950890,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ3-23 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52293,,2300276,CHEMBL950891,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ3-9 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52294,,2300277,CHEMBL950892,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ55 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
52295,,2300278,CHEMBL950893,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ52 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
52296,,2300279,CHEMBL950894,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate DL34 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
52297,,2300280,CHEMBL950895,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate NJ59 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
52298,,2300281,CHEMBL959537,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ32 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
52299,,2300282,CHEMBL959538,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ58 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
52300,,2300283,CHEMBL960331,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ36 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52301,,2300284,CHEMBL960332,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ49 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52302,,2300285,CHEMBL960333,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate CY7 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
52303,,2300286,CHEMBL960334,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate CY6 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.12
52304,,2300287,CHEMBL960335,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZS15 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52305,,2300288,CHEMBL960336,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZS5 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
52306,,2300289,CHEMBL960337,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate FZ4A18 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.12
52307,,2300290,CHEMBL960338,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate FZ84 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
52308,,2300291,CHEMBL960339,Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate JN45 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137659,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784408,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.5
52309,,2304416,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783681,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
52310,,2304422,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783681,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
52311,,2304428,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783681,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
52312,,2304434,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783681,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52313,,2304440,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783681,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
52314,,2304446,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783681,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,32.0
52315,,2346416,CHEMBL954700,"Antimicrobial activity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as survival at 5 mg/kg/day, ip once daily for 5 days administered 2 day after infection",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,794017,=,1,0,=,Survival,%,40.0,CHEMBL613218,Leptospira interrogans serovar Portlandvere,Leptospira interrogans serovar Portlandvere,508528.0,,Survival,%,UO_0000187,40.0
52316,,2346417,CHEMBL954699,"Antimicrobial activity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as survival at 25 mg/kg/day, ip once daily for 5 days administered 2 day after infection",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,794017,=,1,0,=,Survival,%,95.0,CHEMBL613218,Leptospira interrogans serovar Portlandvere,Leptospira interrogans serovar Portlandvere,508528.0,,Survival,%,UO_0000187,95.0
52317,,2346425,CHEMBL954698,"Antimicrobial activity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as survival at 50 mg/kg/day, ip once daily for 5 days administered 2 day after infection",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,794017,=,1,0,=,Survival,%,95.0,CHEMBL613218,Leptospira interrogans serovar Portlandvere,Leptospira interrogans serovar Portlandvere,508528.0,,Survival,%,UO_0000187,95.0
52318,,2347411,CHEMBL957902,Antibacterial activity against Escherichia coli C600Rif by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
52319,,2347418,CHEMBL957904,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
52320,,2347425,CHEMBL957905,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
52321,,2347432,CHEMBL957906,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
52322,,2347439,CHEMBL957907,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
52323,,2347446,CHEMBL957908,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
52324,,2347453,CHEMBL957909,Antibacterial activity against Escherichia coli TOP10 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
52325,,2347460,CHEMBL957910,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
52326,,2347467,CHEMBL957911,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
52327,,2347474,CHEMBL957912,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
52328,,2347481,CHEMBL957913,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
52329,,2347488,CHEMBL957914,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
52330,,2347495,CHEMBL957915,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52331,,2347502,CHEMBL957916,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
52332,,2347509,CHEMBL957917,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793357,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
52333,,2349390,CHEMBL956329,Antimicrobial activity against Acinetobacter baumannii 694 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
52334,,2349403,CHEMBL956328,Antimicrobial activity against Acinetobacter baumannii 696 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
52335,,2349416,CHEMBL956327,Antimicrobial activity against Acinetobacter baumannii 9043 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52336,,2349429,CHEMBL956325,Antimicrobial activity against Acinetobacter baumannii 695 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
52337,,2349442,CHEMBL956324,Antimicrobial activity against Acinetobacter baumannii 501 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
52338,,2349455,CHEMBL955555,Antimicrobial activity against Acinetobacter sp. 5227 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,MIC,ug ml-1,UO_0000274,2.0
52339,,2349468,CHEMBL955554,Antimicrobial activity against Acinetobacter sp. 5248 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,MIC,ug ml-1,UO_0000274,4.0
52340,,2349481,CHEMBL955553,Antimicrobial activity against Pseudomonas putida 12346 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794125,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,MIC,ug ml-1,UO_0000274,4.0
52341,,2351585,CHEMBL959678,Antibacterial activity against Staphylococcus aureus ATCC 29213 by macrotube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793274,=,1,1,=,MIC,ug.mL-1,0.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.16
52342,,2351586,CHEMBL959679,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as logarithmic-growth-phase minimal bactericidal concentration after 24 hrs by macrotube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793274,=,1,0,=,MBC,ug ml-1,0.32,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.32
52343,,2351587,CHEMBL959680,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as stationary-growth-phase minimal bactericidal concentration after 24 hrs by macrotube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793274,=,1,0,=,MBC,ug ml-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,40.0
52344,,2351588,CHEMBL959681,Ratio of MBC for Staphylococcus aureus ATCC 29213 during logarithmic-growth phase to stationary-growth phase,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,793274,=,1,0,=,Ratio,,125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,125.0
52345,,2351589,CHEMBL954715,"Ratio of peak drug level in albino guinea pig cage fluid at 5 mg/kg, ip to MIC for Staphylococcus aureus ATCC 29213",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,793274,=,1,0,=,Ratio,,6.1,CHEMBL612545,,Unchecked,,,Ratio,,,6.1
52346,,2351590,CHEMBL954717,"Ratio of peak drug level in albino guinea pig cage fluid at 5 mg/kg, ip to MIC for Staphylococcus aureus ATCC 29213 during stationary-growth phase",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,793274,=,1,0,=,Ratio,,0.02,CHEMBL612545,,Unchecked,,,Ratio,,,0.02
52347,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2351601,CHEMBL954719,"Cmax in albino guinea pig cage fluid at 5 mg/kg, ip administered as single dose",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,793274,=,1,1,=,Cmax,nM,2684.23,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,Cmax,ug ml-1,UO_0000065,0.97
52348,Not Active,2351614,CHEMBL954727,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected albino guinea pig tissue-cage infection model assessed as effect on bacterial count at 5 mg/kg, ip administered every 12 hrs for 4 days",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,793274,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
52349,Not Active,2351619,CHEMBL954732,"Antibacterial activity against Staphylococcus aureus ATCC 29213 infected albino guinea pig tissue-cage infection model assessed as infection cure rate at 5 mg/kg, ip administered every 12 hrs for 4 days",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157370,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,793274,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
52350,,2351636,CHEMBL954735,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52351,,2351637,CHEMBL954735,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
52352,,2351650,CHEMBL954736,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,792938,=,1,0,=,Activity,%,96.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,96.2
52353,,2351659,CHEMBL954737,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,792938,=,1,0,=,Activity,%,3.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,3.0
52354,,2351664,CHEMBL954738,"Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-1 with gyrA Glu85Lys, ParC Ser79Phe and parE Ile460Val mutation by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,32.0
52355,,2351665,CHEMBL954739,"Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-2 with gyrA Ser81Phe, Ser114Gly, ParC Ser52Gly, Ser79Phe, Asn91Asp and parE Ile460Val mutation by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,8.0
52356,,2351666,CHEMBL954740,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-3 with ParC Ser79Tyr and parE Ile460Val mutation by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,64.0
52357,,2351667,CHEMBL954741,"Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-4 with gyrA Ser81Phe, ParC Lys137Asn and parE Ile460Val, Asp435Asn mutation by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,8.0
52358,,2351668,CHEMBL957193,"Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-5 with ParC Ser79Tyr, Lys137Asn and parE Ile460Val mutation by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,4.0
52359,,2351669,CHEMBL957194,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-6 with parE Ile460Val mutation by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,8.0
52360,,2351670,CHEMBL957195,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-7 with parE Ile460Val mutation by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,64.0
52361,,2351671,CHEMBL957196,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-8 with parE Ile460Val mutation by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,64.0
52362,,2351672,CHEMBL957197,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate-9 with parC Asn94ser and parE Ile460Val mutation by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792938,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug/L,UO_0000274,4.0
52363,,2353283,CHEMBL966106,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
52364,,2353284,CHEMBL966106,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,128.0
52365,,2353299,CHEMBL966107,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
52366,,2353300,CHEMBL966107,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
52367,,2353315,CHEMBL966108,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC50,ug ml-1,UO_0000274,4.0
52368,,2353316,CHEMBL966108,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC90,ug ml-1,UO_0000274,32.0
52369,,2353331,CHEMBL966109,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC50,ug ml-1,UO_0000274,0.25
52370,,2353332,CHEMBL966109,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793587,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,MIC90,ug ml-1,UO_0000274,0.25
52371,,2353372,CHEMBL956442,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent susceptible isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,7.0
52372,,2353379,CHEMBL954856,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent resistant isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,93.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,93.0
52373,,2353385,CHEMBL955596,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent susceptible isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,100.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,Activity,%,UO_0000187,100.0
52374,,2353390,CHEMBL954857,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate assessed as susceptible resistant isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
52375,,2353397,CHEMBL954858,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent resistant isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
52376,,2353403,CHEMBL954859,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent susceptible isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,35.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,Activity,%,UO_0000187,35.0
52377,,2353410,CHEMBL955595,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. assessed as percent resistant isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,60.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,Activity,%,UO_0000187,60.0
52378,,2353418,CHEMBL955597,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent resistant isolates by CLSI dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,793587,=,1,0,=,Activity,%,0.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,Activity,%,UO_0000187,0.0
52379,,2355927,CHEMBL1005206,Antibacterial activity against Staphylococcus aureus Smith after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52380,,2355940,CHEMBL1005208,Antibacterial activity against Streptococcus pneumoniae type 3 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52381,,2355953,CHEMBL1005205,Antibacterial activity against Streptococcus pyogenes IID692 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
52382,,2355966,CHEMBL1005204,Antibacterial activity against Enterococcus faecalis IID682 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
52383,,2355979,CHEMBL1005203,Antibacterial activity against Escherichia coli NIHJ JC2 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.001
52384,,2355992,CHEMBL1005202,Antibacterial activity against Klebsiella pneumoniae IID5209 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.016
52385,,2356005,CHEMBL1005207,Antibacterial activity against Haemophilus influenzae IID983 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
52386,,2356017,CHEMBL1005209,Antibacterial activity against Pseudomonas aeruginosa IID1210 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
52387,,2356036,CHEMBL1005210,Antibacterial activity against quinoline-resistant Staphylococcus aureus OITI MR1-1002 isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
52388,,2356049,CHEMBL1005211,Antibacterial activity against quinoline-resistant Streptococcus pneumoniae no.55 isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52389,,2356062,CHEMBL1005212,Antibacterial activity against quinoline-resistant Enterococcus faecalis No.15 isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
52390,,2356075,CHEMBL1005213,Antibacterial activity against vancomycin-resistant Enterococcus faecalis KU1856 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
52391,,2356088,CHEMBL1005214,Antibacterial activity against vancomycin-resistant Enterococcus faecalis KU1866 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
52392,,2357183,CHEMBL1005224,Antibacterial activity against quinoline-resistant wild type Staphylococcus aureus MS5935 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
52393,,2357184,CHEMBL1005225,Antibacterial activity against quinoline-resistant Staphylococcus aureus MS5935 containing single grlA mutation after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
52394,,2357185,CHEMBL1005226,Antibacterial activity against quinoline-resistant Staphylococcus aureus MS5935 containing single grlA and single gyrA mutation after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
52395,,2357186,CHEMBL1005227,Antibacterial activity against quinoline-resistant Staphylococcus aureus MS5935 containing double grlA and single gyrA mutation after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
52396,,2357187,CHEMBL1005228,Antibacterial activity against quinoline-resistant Staphylococcus aureus MS5935 containing double grlA and double gyrA mutation after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
52397,,2357204,CHEMBL1005220,Inhibition of Staphylococcus aureus MS5935 wild type DNA gyrase-mediated supercoiling activity,B,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,IC50,ug.mL-1,9.31,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,ug ml-1,UO_0000274,9.31
52398,,2357205,CHEMBL1005221,Inhibition of quinoline-resistant Staphylococcus aureus MS5935 DNA gyrase-mediated supercoiling activity,B,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,IC50,ug.mL-1,772.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,ug ml-1,UO_0000274,772.0
52399,,2357206,CHEMBL1005222,Inhibition of Staphylococcus aureus MS5935 wild type topoisomerase 4-mediated decatenation activity,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,IC50,ug.mL-1,5.44,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,5.44
52400,,2357207,CHEMBL1005223,Inhibition of quinoline-resistant Staphylococcus aureus MS5935 topoisomerase 4-mediated decatenation activity,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1150336,J Med Chem,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,766125,=,1,1,=,IC50,ug.mL-1,319.0,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,319.0
52401,,2495061,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779482,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52402,,2495062,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779482,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52403,,2495068,CHEMBL1028013,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,779482,=,1,0,=,Activity,%,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,4.0
52404,,2495080,CHEMBL1028014,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779482,>=,1,0,>=,Activity,ug ml-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,8.0
52405,,2495090,CHEMBL1028015,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779482,<=,1,0,<=,Activity,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,2.0
52406,,2495095,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779482,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52407,,2495958,CHEMBL1028842,Antimicrobial activity against beta-lactamase negative ampicillin-susceptible Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
52408,,2495961,CHEMBL1028843,Antimicrobial activity against beta-lactamase negative ampicillin-susceptible Haemophilus influenzae by E-test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
52409,,2495964,CHEMBL1028844,Antimicrobial activity against beta-lactamase negative ampicillin-resistant Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
52410,,2495967,CHEMBL1028845,Antimicrobial activity against beta-lactamase negative ampicillin-resistant Haemophilus influenzae by E-test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.016
52411,,2495970,CHEMBL1028846,Antimicrobial activity against beta-lactamase positive ampicillin-resistant Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
52412,,2495973,CHEMBL1028847,Antimicrobial activity against beta-lactamase positive ampicillin-resistant Haemophilus influenzae by E-test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
52413,,2495976,CHEMBL1028848,Antimicrobial activity against beta-lactamase positive amoxicillin/clavulanate-resistant Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
52414,,2495979,CHEMBL1028849,Antimicrobial activity against beta-lactamase positive amoxicillin/clavulanate-resistant Haemophilus influenzae by E-test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154406,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779723,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
52415,,2496237,CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.25
52416,,2496248,CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.5
52417,,2496259,CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.5
52418,,2496270,CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,<=,1,1,<=,MIC,ug.mL-1,0.12,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC,mg/L,UO_0000274,0.12
52419,,2497046,CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,mg/L,UO_0000274,0.25
52420,,2497057,CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,mg/L,UO_0000274,0.25
52421,,2497134,CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,mg/L,UO_0000274,0.5
52422,,2497145,CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,mg/L,UO_0000274,0.5
52423,,2497156,CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,mg/L,UO_0000274,0.5
52424,,2497167,CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC50,mg/L,UO_0000274,0.5
52425,,2497178,CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC50,mg/L,UO_0000274,0.5
52426,,2497189,CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,mg/L,UO_0000274,0.5
52427,,2497264,CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,1.0
52428,,2497275,CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,1.0
52429,,2497286,CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,4.0
52430,,2497297,CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC90,mg/L,UO_0000274,0.5
52431,,2497308,CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC90,mg/L,UO_0000274,1.0
52432,,2497319,CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780220,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,mg/L,UO_0000274,1.0
52433,,2498167,CHEMBL1030565,Antibacterial activity against Staphylococcus aureus RN4220 by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52434,,2498168,CHEMBL1030566,Antibacterial activity against Staphylococcus aureus RN4220 containing ORI23 promoter by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52435,,2498169,CHEMBL1030567,Antibacterial activity against Staphylococcus aureus RN4220 containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
52436,,2498170,CHEMBL1030568,Antibacterial activity against Lactococcus lactis IL-1419 by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,0.5
52437,,2498171,CHEMBL1033151,Antibacterial activity against Lactococcus lactis IL-1419 containing ORI23 promoter by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,0.5
52438,,2498172,CHEMBL1020335,Antibacterial activity against Lactococcus lactis IL-1419 containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,2.0
52439,,2498173,CHEMBL1020336,Antibacterial activity against Escherichia coli DH10B by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52440,,2498174,CHEMBL1020337,Antibacterial activity against Escherichia coli DH10B containing ORI23 promoter by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52441,,2498175,CHEMBL1020338,Antibacterial activity against Escherichia coli DH10B containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779206,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
52442,,2499753,CHEMBL992264,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779082,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
52443,,2499775,CHEMBL992265,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779082,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
52444,,2499797,CHEMBL992266,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779082,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
52445,,2499819,CHEMBL992267,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779082,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
52446,,2499841,CHEMBL992268,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779082,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
52447,,2499863,CHEMBL992269,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779082,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
52448,,2499885,CHEMBL992270,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,779082,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
52449,,2501801,CHEMBL982536,Antibacterial activity against multidrug-resistant Acinetobacter baumannii 06-74 isolate by CLSI microdilution test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1143418,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779870,>=,1,1,>=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
52450,,2502039,CHEMBL1021213,Antibacterial activity against Streptococcus pneumoniae Hex-deficient mutant by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52451,,2502040,CHEMBL1021214,"Antibacterial activity against Streptococcus pneumoniae D39-2 with gyrA S81F, parE D435N mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52452,,2502041,CHEMBL1021215,"Antibacterial activity against Streptococcus pneumoniae D39-3 with parC S79Y, gyrA S81F mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52453,,2502042,CHEMBL1021216,"Antibacterial activity against Streptococcus pneumoniae D39-19 with parC D83N, gyrA S81Y mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52454,,2502043,CHEMBL1021217,Antibacterial activity against Streptococcus pneumoniae D39 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52455,,2502044,CHEMBL1021218,"Antibacterial activity against Streptococcus pneumoniae 2530 with parC D83N, gyrA S81F mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52456,,2502045,CHEMBL1021219,"Antibacterial activity against Streptococcus pneumoniae 1237 with parC S79F, gyrA S81Y mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52457,,2502046,CHEMBL1021220,"Antibacterial activity against Streptococcus pneumoniae 455 with parC S79Y, gyrA S81F mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52458,,2502047,CHEMBL1021221,"Antibacterial activity against Streptococcus pneumoniae 3386 with parC S79F, gyrA S81F mutation by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154429,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778827,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52459,Active,2556435,CHEMBL993693,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 5 days",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52460,Active,2556438,CHEMBL993692,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 5 days",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52461,,2556446,CHEMBL993690,Drug level in Clostridium difficile infected CF1 mouse stool at 0.375 mg/day for 4 days,A,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,=,1,0,=,Drug uptake,ug/g,58.1,CHEMBL612558,,ADMET,,,Drug uptake,ug/g,,58.1
52462,Active,2556449,CHEMBL991815,Effect on growth of nonepidemic Clostridium difficile J29 in sc dosed CF1 mouse assessed as increase in bacterial overgrowth in cecal content administered 20 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52463,Active,2556450,CHEMBL991814,Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in sc dosed CF1 mouse assessed as increase in bacterial overgrowth in cecal content administered 20 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52464,Active,2556457,CHEMBL993688,Increase in toxin level in epidemic Clostridium difficile BI6-8-17 infected CF1 mouse administered 20 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52465,Active,2556458,CHEMBL993687,Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse administered 20 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52466,Active,2556460,CHEMBL993686,Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse administered 20 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52467,Active,2556461,CHEMBL993685,Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected CF1 mouse administered 20 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52468,,2556470,CHEMBL990922,Antimicrobial activity against nonepidemic Clostridium difficile ATCC 9689 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743670,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
52469,,2556475,CHEMBL990923,Antimicrobial activity against nonepidemic Clostridium difficile J29 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743670,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
52470,,2556480,CHEMBL990924,Antimicrobial activity against epidemic Clostridium difficile BI9 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743670,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
52471,,2556485,CHEMBL990925,Antimicrobial activity against epidemic Clostridium difficile BI6-8-17 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743670,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
52472,,2556490,CHEMBL990926,Antimicrobial activity against fluoroquinolone-resistant epidemic Clostridium difficile NAP1 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743670,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
52473,,2556495,CHEMBL990927,Antimicrobial activity against fluoroquinolone-susceptible nonepidemic Clostridium difficile strain6 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743670,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
52474,Not Active,2556509,CHEMBL994406,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52475,Not Active,2556510,CHEMBL994407,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52476,Not Active,2556511,CHEMBL994408,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52477,Not Active,2556512,CHEMBL994409,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52478,Not Active,2556584,CHEMBL993695,Effect on growth of fluoroquinolone-susceptible epidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content dosed sc for 5 days,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52479,Active,2556589,CHEMBL993694,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 2.0 mg/day, sc for 5 days",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52480,Active,2556592,CHEMBL991816,Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in sc dosed CF1 mouse assessed as increase in bacterial overgrowth in cecal content administered 12 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52481,Active,2556593,CHEMBL994405,Effect on growth of nonepidemic Clostridium difficile J29 in sc dosed CF1 mouse assessed as increase in bacterial overgrowth in cecal content administered 12 times the usual human dose for 4 days assessed after 2 days of last treatment,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743670,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
52482,,2572745,CHEMBL990932,Antimicrobial activity against Streptococcus pneumoniae L5 with parE Ile460Val mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52483,,2572746,CHEMBL990933,"Antimicrobial activity against Streptococcus pneumoniae L6 with gyrA Ser81Phe, parC Lys137Asn and parE Ile460Val mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52484,,2572747,CHEMBL990934,"Antimicrobial activity against Streptococcus pneumoniae L12 with gyrA Ser81Phe, parC Ser79 Phe and parE Ile460Val mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52485,,2572748,CHEMBL990935,Antimicrobial activity against Streptococcus pneumoniae L13 with parC Asp83Tyr and parE Ile460Val mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52486,,2572749,CHEMBL990936,Antimicrobial activity against Streptococcus pneumoniae L14 with parC Lys137Asn and parE Ile460Val mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52487,,2572750,CHEMBL990937,Antimicrobial activity against Streptococcus pneumoniae L15 with parC Asp83Asn Lys137Asn and parE Ile460Val mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52488,,2572751,CHEMBL990938,Antimicrobial activity against Streptococcus pneumoniae L22 with parC Lys137Asn and parE Ile460Val mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52489,,2572752,CHEMBL990939,"Antimicrobial activity against Streptococcus pneumoniae L24 with gyrA Ser81Phe, gyrB Ser494Thr, parC Asp83Asn, Lys137Asn and parE Ile460Val mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52490,,2572753,CHEMBL990940,"Antimicrobial activity against Viridans streptococcus L2 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,2.0
52491,,2572754,CHEMBL990941,"Antimicrobial activity against Viridans streptococcus L7 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,2.0
52492,,2572755,CHEMBL990942,"Antimicrobial activity against Viridans streptococcus L16 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,1.0
52493,,2572756,CHEMBL990943,"Antimicrobial activity against Viridans streptococcus L17 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,1.0
52494,,2572757,CHEMBL990944,"Antimicrobial activity against Viridans streptococcus L18 with gyrA Ser114Gly, Asp142Asn, gyrB Ser494Thr and parE Ile460Val mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,2.0
52495,,2572758,CHEMBL990945,"Antimicrobial activity against Viridans streptococcus L19 with gyrA Ser114Gly, gyrB Ser494Thr, parC Ser52Gly, Asn91Asp and parE Ile460Val mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,2.0
52496,,2572759,CHEMBL990946,"Antimicrobial activity against Viridans streptococcus L20 with gyrB Ser494Thr, parC Ser52Gly and Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,2.0
52497,,2572760,CHEMBL990947,Antimicrobial activity against Viridans streptococcus L21 with gyrB Ser494Thr and parC Lys137Asn mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,2.0
52498,,2572761,CHEMBL990948,Antimicrobial activity against Viridans streptococcus L26 gyrA Ser81Phe and parC Lys137Asn mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,16.0
52499,,2572762,CHEMBL990949,Antimicrobial activity against atypical Streptococcus pneumoniae L3 with parC Lys137Asn mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52500,,2572763,CHEMBL990950,"Antimicrobial activity against atypical Streptococcus pneumoniae L8 with parC Ser52Gly, Phe55His, Ser58Gly, Asn91Asp, Lys197Asn mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52501,,2572764,CHEMBL990951,"Antimicrobial activity against atypical Streptococcus pneumoniae L9 with gyrA Ser114Gly, gyrB Ser494Thr and parC Lys137Asn mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52502,,2572765,CHEMBL990952,Antimicrobial activity against atypical Streptococcus pneumoniae L10 with gyrA Ser81Phe and parC Lys197Asn mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52503,,2572766,CHEMBL990953,Antimicrobial activity against atypical Streptococcus pneumoniae L4 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52504,,2572767,CHEMBL990954,"Antimicrobial activity against atypical Streptococcus pneumoniae L1 with gyrA Ser81Phe and parC Ser79Phe, Glu96Asp, Lys197Asn mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52505,,2572768,CHEMBL988220,Antimicrobial activity against atypical Streptococcus pneumoniae L25 with parC Lys137Asn mutation by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52506,,2572769,CHEMBL988221,"Antimicrobial activity against atypical Streptococcus pneumoniae L27 with parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52507,,2572770,CHEMBL988222,"Antimicrobial activity against atypical Streptococcus pneumoniae L11 with parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52508,,2572806,CHEMBL988223,Antimicrobial activity against Streptococcus pneumoniae R6 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52509,,2572807,CHEMBL988224,"Antimicrobial activity against Streptococcus oralis ATCC 10557 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52510,,2572808,CHEMBL988225,"Antimicrobial activity against Streptococcus oralis HK575 with gyrA Ser114Gly, Leu155Val and parC Ser52Gly, Asn91Asp, Pro140Ser mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52511,,2572809,CHEMBL988226,"Antimicrobial activity against Streptococcus oralis HK232 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52512,,2572810,CHEMBL988227,"Antimicrobial activity against Streptococcus oralis HK417 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52513,,2572811,CHEMBL988228,"Antimicrobial activity against Streptococcus oralis HK496 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52514,,2572812,CHEMBL988229,"Antimicrobial activity against Streptococcus oralis HK553 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52515,,2572813,CHEMBL988230,"Antimicrobial activity against Streptococcus oralis HK62 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52516,,2572814,CHEMBL988231,"Antimicrobial activity against Streptococcus oralis HK122 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52517,,2572815,CHEMBL988232,"Antimicrobial activity against Streptococcus oralis HK123 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52518,,2572816,CHEMBL988233,"Antimicrobial activity against Streptococcus oralis HK271 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52519,,2572817,CHEMBL988234,"Antimicrobial activity against Streptococcus oralis HK300 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52520,,2572818,CHEMBL988236,"Antimicrobial activity against Streptococcus oralis HK51with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52521,,2572819,CHEMBL988237,"Antimicrobial activity against Streptococcus oralis HK299 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52522,,2572820,CHEMBL988238,"Antimicrobial activity against Streptococcus oralis HK579 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52523,,2572821,CHEMBL988239,"Antimicrobial activity against Streptococcus oralis HK587 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52524,,2572822,CHEMBL988240,"Antimicrobial activity against Streptococcus oralis HK386 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52525,,2572823,CHEMBL988241,"Antimicrobial activity against Streptococcus oralis HK619 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52526,,2572824,CHEMBL988242,"Antimicrobial activity against Streptococcus oralis HK574 with gyrA Ser114Gly, Leu155Val, gyrB Ile385Val, Met483Thr, Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,2.0
52527,,2572825,CHEMBL988243,"Antimicrobial activity against Streptococcus oralis HK816 with gyrA Ser81Leu, Ser114Gly and parC Ser52Gly, Ser79Tyr, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,32.0
52528,,2572826,CHEMBL988244,"Antimicrobial activity against Streptococcus oralis HK754 with gyrA Ser81Leu, Ser114Gly, gyrB Ser494Thr, parC Ser52Gly, Asp83Tyr, Asn91Asp and parE Arg447Ser mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,32.0
52529,,2572827,CHEMBL988245,"Antimicrobial activity against Streptococcus mitis ATCC 49456 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,1.0
52530,,2572828,CHEMBL988246,"Antimicrobial activity against Streptococcus mitis HK260 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.25
52531,,2572829,CHEMBL988247,"Antimicrobial activity against Streptococcus mitis HK141 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.5
52532,,2572830,CHEMBL988248,"Antimicrobial activity against Streptococcus mitis HK188 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.5
52533,,2572831,CHEMBL988249,"Antimicrobial activity against Streptococcus mitis HK651 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.5
52534,,2572832,CHEMBL988250,"Antimicrobial activity against Streptococcus mitis HK137453 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,1.0
52535,,2572833,CHEMBL989132,"Antimicrobial activity against Streptococcus mitis HK680 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,1.0
52536,,2572834,CHEMBL989133,"Antimicrobial activity against Streptococcus mitis HK125807 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,1.0
52537,,2572835,CHEMBL989134,"Antimicrobial activity against Streptococcus mitis HK467 with gyrA Ser114Gly, Leu155Val and parC Ser52Gly, Asn91Asp, mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,1.0
52538,,2572836,CHEMBL989135,"Antimicrobial activity against Streptococcus mitis HK666 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,2.0
52539,,2572837,CHEMBL989136,"Antimicrobial activity against Streptococcus mitis HK135786 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,1.0
52540,,2572838,CHEMBL989137,"Antimicrobial activity against Streptococcus mitis HK29 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,2.0
52541,,2572839,CHEMBL989138,"Antimicrobial activity against Streptococcus mitis HK677 with gyrA Ser81Leu, Ser114Gly, gyrB Ser494Thr, parC Ser52Gly, Asp83Tyr, Asn91Asp and parE Arg447Ser mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,32.0
52542,,2572840,CHEMBL988235,"Antimicrobial activity against Streptococcus oralis HK312 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742538,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,1.0
52543,,2576490,CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743072,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC50,ug ml-1,UO_0000274,4.0
52544,,2576491,CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743072,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC90,ug ml-1,UO_0000274,32.0
52545,,2576516,CHEMBL988172,Antimicrobial activity against levofloxacin-resistant Yersinia pestis mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155150,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743073,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,mg/L,UO_0000274,1.0
52546,,2576520,CHEMBL988158,Antibacterial activity against Yersinia pestis delta CO92 by broth macrodilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155150,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,743073,=,1,0,=,MBC,mg/L,0.125,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MBC,mg/L,,0.125
52547,,2576527,CHEMBL988158,Antibacterial activity against Yersinia pestis delta CO92 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155150,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743073,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,mg/L,UO_0000274,0.06
52548,,2576529,CHEMBL988161,Antimicrobial activity against antibiotic-resistant Yersinia pestis mutant on day 4 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155150,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743073,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,mg/L,UO_0000274,0.25
52549,,2576530,CHEMBL988162,Antimicrobial activity against antibiotic-resistant Yersinia pestis mutant on day 6 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155150,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743073,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,mg/L,UO_0000274,0.5
52550,,2576531,CHEMBL988163,Antimicrobial activity against antibiotic-resistant Yersinia pestis mutant on day 10 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155150,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743073,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,mg/L,UO_0000274,0.5
52551,,2627511,CHEMBL964427,Antibacterial activity against Pseudomonas aeruginosa PAO1 by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.5
52552,,2627512,CHEMBL964428,Antibacterial activity against hypermutable Pseudomonas aeruginosa isolate 12-09-15 by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,128.0
52553,,2627513,CHEMBL965217,Antibacterial activity against Pseudomonas aeruginosa PAO1/MEM mutant by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.5
52554,,2627514,CHEMBL965218,Antibacterial activity against hypermutable Pseudomonas aeruginosa 12-09-15/MEM mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,64.0
52555,,2627515,CHEMBL938060,Antibacterial activity against hypermutable Pseudomonas aeruginosa 12-09-15/MEM mutant in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,1.0
52556,,2627516,CHEMBL965220,Antibacterial activity against Pseudomonas aeruginosa PAO1 in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.06
52557,,2627517,CHEMBL952706,Antibacterial activity against hypermutable Pseudomonas aeruginosa isolate 12-09-15 in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,2.0
52558,,2627518,CHEMBL952707,Antibacterial activity against Pseudomonas aeruginosa PAO1/MEM mutant in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.12
52559,,2627519,CHEMBL965219,Antibacterial activity against Pseudomonas aeruginosa PAO1/CAZ mutant by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.5
52560,,2627520,CHEMBL938063,Ratio of MIC for Pseudomonas aeruginosa PAO1/CAZ mutant in absence of efflux pump inhibitor Phe-Arg-beta-naphthylamide to MIC for Pseudomonas aeruginosa PAO1/CAZ mutant in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,792071,=,1,0,=,Ratio,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,8.0
52561,,2627521,CHEMBL938061,Antibacterial activity against Pseudomonas aeruginosa PAO1/CAZ mutant in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792071,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.06
52562,,2627522,CHEMBL965221,Ratio of MIC for Pseudomonas aeruginosa PAO1 in absence of efflux pump inhibitor Phe-Arg-beta-naphthylamide to MIC for Pseudomonas aeruginosa PAO1 in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,792071,=,1,0,=,Ratio,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,8.0
52563,,2627523,CHEMBL952708,Ratio of MIC for hypermutable Pseudomonas aeruginosa isolate 12-09-15 in absence of efflux pump inhibitor Phe-Arg-beta-naphthylamide to MIC for hypermutable Pseudomonas aeruginosa isolate 12-09-15 in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,792071,=,1,0,=,Ratio,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,64.0
52564,,2627524,CHEMBL952709,Ratio of MIC for Pseudomonas aeruginosa PAO1/MEM mutant in absence of efflux pump inhibitor Phe-Arg-beta-naphthylamide to MIC for Pseudomonas aeruginosa PAO1/MEM mutant in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,792071,=,1,0,=,Ratio,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,4.0
52565,,2627525,CHEMBL938062,Ratio of MIC for hypermutable Pseudomonas aeruginosa isolate 12-09-15/MEM mutant in absence of efflux pump inhibitor Phe-Arg-beta-naphthylamide to MIC for hypermutable Pseudomonas aeruginosa isolate 12-09-15//MEM mutant in presence of efflux pump inhibitor Phe-Arg-beta-naphthylamide,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137630,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,792071,=,1,0,=,Ratio,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,64.0
52566,,2628702,CHEMBL956218,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791981,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.06
52567,,2628703,CHEMBL956219,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791981,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.06
52568,,2628704,CHEMBL956220,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791981,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.06
52569,,2628726,CHEMBL956218,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791981,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
52570,,2628727,CHEMBL956219,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791981,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
52571,,2628728,CHEMBL956220,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,791981,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
52572,,2628747,CHEMBL957019,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene assessed as susceptibility rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,791981,=,1,0,=,Activity,%,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,100.0
52573,,2628748,CHEMBL958670,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene assessed as susceptibility rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,791981,=,1,0,=,Activity,%,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,100.0
52574,,2628749,CHEMBL959506,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene assessed as susceptibility rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,791981,=,1,0,=,Activity,%,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,100.0
52575,,2628768,CHEMBL959510,Antibacterial activity against genetically beta-lactamase-negative ampicillin-susceptible Haemophilus influenzae type b without amino acid substitutions in ftsI gene and bla gene assessed as resistance rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,791981,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
52576,,2628769,CHEMBL959511,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in variable mutated locus Asn-526 or Arg-517 of ftsI gene assessed as resistance rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,791981,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
52577,,2628770,CHEMBL959512,Antibacterial activity against genetically beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b with an amino acid substitution in highly mutated locus Ser-385 of ftsI gene assessed as resistance rate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137636,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,791981,=,1,0,=,Activity,%,0.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,0.0
52578,,2631731,CHEMBL1004059,Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS3 transconjugant from Citrobacter freundii 64 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784026,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
52579,,2631732,CHEMBL1004060,Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS4 transconjugant from Enterobacter cloacae 91 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784026,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
52580,,2631733,CHEMBL1006592,Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS5 transconjugant from Enterobacter cloacae 641 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784026,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
52581,,2631734,CHEMBL1006593,Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS6 transconjugant from Escherichia coli 650 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784026,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
52582,,2631735,CHEMBL1006594,Antimicrobial activity against azide-resistant Escherichia coli J53 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784026,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
52583,,2632659,CHEMBL963547,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as spleen bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,4.48,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,log10cfu,,,4.48
52584,,2632660,CHEMBL963546,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as liver bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,5.16,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,log10cfu,,,5.16
52585,,2632661,CHEMBL963545,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as lung bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,5.47,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,log10cfu,,,5.47
52586,,2632665,CHEMBL963541,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as spleen bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,9.38,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,log10cfu,,,9.38
52587,,2632666,CHEMBL963540,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as liver bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,9.92,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,log10cfu,,,9.92
52588,,2632667,CHEMBL963539,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as lung bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,9.01,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,log10cfu,,,9.01
52589,,2632680,CHEMBL963551,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as lung bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,5.48,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,5.48
52590,,2632681,CHEMBL963552,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as liver bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,6.52,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,6.52
52591,,2632682,CHEMBL963553,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as spleen bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,6.72,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,6.72
52592,,2632692,CHEMBL999001,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as lung bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,7.82,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.82
52593,,2632693,CHEMBL999002,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as liver bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,7.77,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.77
52594,,2632694,CHEMBL999003,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as spleen bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,7.58,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.58
52595,,2632708,CHEMBL962730,Antimycobacterial activity against Mycobacterium avium JATA51-01 after 14 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783319,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,4.0
52596,,2632709,CHEMBL962731,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 after 14 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783319,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,MIC,ug ml-1,UO_0000274,4.0
52597,,2632710,CHEMBL962732,Antimycobacterial activity against Mycobacterium avium complex N016 after 14 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783319,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,MIC,ug ml-1,UO_0000274,2.0
52598,,2632711,CHEMBL962733,Antimycobacterial activity against Mycobacterium avium complex N018 after 14 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783319,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,MIC,ug ml-1,UO_0000274,4.0
52599,,2632712,CHEMBL963534,Antimycobacterial activity against Mycobacterium avium complex N084 after 14 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783319,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,MIC,ug ml-1,UO_0000274,8.0
52600,,2632720,CHEMBL963535,Antimycobacterial activity against Mycobacterium avium complex after 14 days by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783319,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,MIC90,ug ml-1,UO_0000274,16.0
52601,,2632728,CHEMBL949906,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as lung bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,6.01,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,6.01
52602,,2632729,CHEMBL949905,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as liver bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,7.4,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.4
52603,,2632730,CHEMBL949907,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as spleen bacterial count at 200 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,783319,=,1,0,=,log10cfu,,6.82,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,6.82
52604,,2659598,CHEMBL1051483,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52605,,2659599,CHEMBL1051473,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52606,,2659600,CHEMBL1051468,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52607,,2659601,CHEMBL1051460,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52608,,2659602,CHEMBL1062983,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52609,,2659603,CHEMBL1023504,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52610,,2659604,CHEMBL1023494,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52611,,2659605,CHEMBL1023488,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52612,,2659606,CHEMBL1036288,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52613,,2659607,CHEMBL1036283,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52614,,2659608,CHEMBL1052242,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52615,,2659609,CHEMBL1052246,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 by NCCLS M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52616,,2659854,CHEMBL1051478,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 25 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52617,,2659855,CHEMBL1051477,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 21 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52618,,2659856,CHEMBL1051476,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 18 passages with levofloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52619,,2659857,CHEMBL1051475,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 19 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52620,,2659858,CHEMBL1051470,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52621,,2659859,CHEMBL1051469,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 35 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52622,,2659860,CHEMBL1051464,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 15 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52623,,2659861,CHEMBL1051462,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 29 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52624,,2659862,CHEMBL1051461,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 49 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52625,,2659863,CHEMBL1062986,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52626,,2659864,CHEMBL1062985,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 26 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52627,,2659865,CHEMBL1062984,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 38 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52628,,2659866,CHEMBL1062979,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52629,,2659867,CHEMBL1062978,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 44 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52630,,2659868,CHEMBL1023505,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52631,,2659869,CHEMBL1023498,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 29 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52632,,2659870,CHEMBL1023497,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 33 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52633,,2659871,CHEMBL1023496,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 41 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52634,,2659872,CHEMBL1023495,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 20 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52635,,2659873,CHEMBL1023490,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52636,,2659874,CHEMBL1052241,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52637,,2659875,CHEMBL1023489,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 49 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52638,,2659876,CHEMBL1023485,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52639,,2659877,CHEMBL1023484,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52640,,2659878,CHEMBL1036285,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 20 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52641,,2659879,CHEMBL1036284,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 14 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52642,,2659880,CHEMBL1036280,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 48 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52643,,2659881,CHEMBL1052245,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52644,,2659882,CHEMBL1052249,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 30 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52645,,2660229,CHEMBL1051480,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 18 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52646,,2660236,CHEMBL1051474,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52647,,2660244,CHEMBL1051467,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52648,,2660254,CHEMBL1051459,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52649,,2660262,CHEMBL1062982,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52650,,2660272,CHEMBL1023503,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52651,,2660281,CHEMBL1023493,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52652,,2660287,CHEMBL1023487,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52653,,2660294,CHEMBL1036289,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52654,,2660303,CHEMBL1036282,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52655,,2660309,CHEMBL1052243,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52656,,2660317,CHEMBL1052247,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818309,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52657,,2660916,CHEMBL1028720,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
52658,,2660917,CHEMBL1028721,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,99.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.7
52659,,2660918,CHEMBL1028722,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,98.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.8
52660,,2660919,CHEMBL1028723,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,98.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.0
52661,,2660920,CHEMBL1031224,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.6
52662,,2660921,CHEMBL1031225,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.2
52663,,2660922,CHEMBL1031226,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.9
52664,,2660923,CHEMBL1032050,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.6
52665,,2660948,CHEMBL1028716,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52666,,2660949,CHEMBL1028717,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52667,,2660950,CHEMBL1028718,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52668,,2660951,CHEMBL1028719,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52669,,2660976,CHEMBL1028716,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52670,,2660977,CHEMBL1028717,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52671,,2660978,CHEMBL1028718,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52672,,2660979,CHEMBL1028719,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52673,,2660995,CHEMBL1032051,Antibacterial activity against Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.06
52674,,2660996,CHEMBL1032052,Antibacterial activity against beta lactamase-positive Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.06
52675,,2660997,CHEMBL1032053,Antibacterial activity against beta lactamase-negative Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.06
52676,,2661013,CHEMBL1032051,Antibacterial activity against Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
52677,,2661014,CHEMBL1032052,Antibacterial activity against beta lactamase-positive Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
52678,,2661015,CHEMBL1032053,Antibacterial activity against beta lactamase-negative Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
52679,,2661034,CHEMBL1032054,Antibacterial activity against Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,99.9,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,99.9
52680,,2661035,CHEMBL1032055,Antibacterial activity against beta lactamase-positive Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,100.0
52681,,2661036,CHEMBL1032056,Antibacterial activity against beta lactamase-negative Haemophilus influenzae ATCC 49247 isolated from respiratory tract infected patients assessed as susceptible isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,99.7,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,%,UO_0000187,99.7
52682,,2661041,CHEMBL1032060,Antibacterial activity against Moraxella catarrhalis isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC50,ug.mL-1,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.06
52683,,2661048,CHEMBL1032060,Antibacterial activity against Moraxella catarrhalis isolated from respiratory tract infected patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,<=,1,1,<=,MIC90,ug.mL-1,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.06
52684,,2661097,CHEMBL1032061,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients within 2 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52685,,2661098,CHEMBL1032062,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 3 to 5 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52686,,2661099,CHEMBL1032063,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 6 to 14 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52687,,2661100,CHEMBL1032064,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 15 to 64 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52688,,2661101,CHEMBL1032065,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients more than 65 years of age after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52689,,2661102,CHEMBL1032066,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients within 2 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
52690,,2661103,CHEMBL1032067,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 3 to 5 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
52691,,2661104,CHEMBL1032068,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 6 to 14 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
52692,,2661105,CHEMBL1032069,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients with 15 to 64 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.4
52693,,2661106,CHEMBL1032070,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected patients more than 65 years of age assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,1.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.4
52694,,2661107,CHEMBL1032071,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected male patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52695,,2661108,CHEMBL1032072,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected male patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.8
52696,,2661109,CHEMBL1032073,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected female patients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52697,,2661110,CHEMBL1032074,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected female patients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.3
52698,,2661111,CHEMBL1032075,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected inpatients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52699,,2661112,CHEMBL1032076,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected inpatients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.1
52700,,2661113,CHEMBL1032077,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected outpatients after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817552,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52701,,2661114,CHEMBL1032078,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 isolated from respiratory tract infected outpatients assessed as resistant isolates after 20 to 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151433,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,817552,=,1,0,=,Activity,%,0.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.9
52702,,2662317,CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
52703,,2662325,CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
52704,,2662333,CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
52705,,2662341,CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
52706,,2662988,CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,MIC,ug ml-1,UO_0000274,0.25
52707,,2663005,CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,MIC90,ug ml-1,UO_0000274,0.5
52708,,2663022,CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,MIC50,ug ml-1,UO_0000274,0.25
52709,,2663039,CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,MIC,ug ml-1,UO_0000274,0.25
52710,Not Determined,2663074,CHEMBL1028803,Antimicrobial activity against Dialister pneumosintes assessed as susceptibility breakpoint by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,818318,,1,0,,Activity,,,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,Activity,,,
52711,Not Determined,2663090,CHEMBL1028804,Antimicrobial activity against Dialister micraerophilus assessed as susceptibility breakpoint by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,818318,,1,0,,Activity,,,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,Activity,,,
52712,,2663106,CHEMBL1028805,Antimicrobial activity against Dialister pneumosintes assessed as susceptibility breakpoint by CA-SFM method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,<=,1,0,<=,Activity,ug ml-1,1.0,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,Activity,ug ml-1,UO_0000274,1.0
52713,,2663123,CHEMBL1028806,Antimicrobial activity against Dialister micraerophilus assessed as susceptibility breakpoint by CA-SFM method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,<=,1,0,<=,Activity,ug ml-1,1.0,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,Activity,ug ml-1,UO_0000274,1.0
52714,,2663140,CHEMBL1028809,Antimicrobial activity against Dialister propionicifaciens by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,MIC,ug ml-1,UO_0000274,0.25
52715,Not Determined,2663157,CHEMBL1028810,Antimicrobial activity against Dialister invisus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,818318,,1,0,,MIC,,,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,MIC,,,
52716,Not Determined,2663174,CHEMBL1028811,Antimicrobial activity against Dialister propionicifaciens assessed as susceptibility breakpoint by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,818318,,1,0,,Activity,,,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,Activity,,,
52717,Not Determined,2663191,CHEMBL1028812,Antimicrobial activity against Dialister invisus assessed as susceptibility breakpoint by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,818318,,1,0,,Activity,,,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,Activity,,,
52718,,2663208,CHEMBL1028813,Antimicrobial activity against Dialister propionicifaciens assessed as susceptibility breakpoint by CA-SFM method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,<=,1,0,<=,Activity,ug ml-1,1.0,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,Activity,ug ml-1,UO_0000274,1.0
52719,,2663224,CHEMBL1028814,Antimicrobial activity against Dialister invisus assessed as susceptibility breakpoint by CA-SFM method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818318,<=,1,0,<=,Activity,ug ml-1,1.0,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,Activity,ug ml-1,UO_0000274,1.0
52720,,2663963,CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,64.0
52721,,2663971,CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
52722,,2663979,CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818894,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
52723,,2674023,CHEMBL1026151,Antibacterial activity against Streptococcus pneumoniae HMC 3041 after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52724,,2674031,CHEMBL1026149,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52725,,2674037,CHEMBL1026148,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52726,,2674042,CHEMBL1026147,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52727,,2674048,CHEMBL1026146,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52728,,2674054,CHEMBL1026145,"Antibacterial activity against penicillin-, quinolone-resistant Streptococcus pneumoniae HMC 1541 harboring mutation in L4 protein by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52729,,2674060,CHEMBL1026144,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52730,,2674066,CHEMBL1026143,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52731,,2674072,CHEMBL1026142,"Antibacterial activity against penicillin-, quinolone-resistant and macrolide-susceptible Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52732,,2674078,CHEMBL1031971,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52733,,2674084,CHEMBL1031970,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 441 expressing ermB by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52734,,2674090,CHEMBL1031969,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52735,,2674096,CHEMBL1031968,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52736,,2674102,CHEMBL1031967,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52737,,2674108,CHEMBL1031966,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52738,,2674114,CHEMBL1031965,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52739,,2674120,CHEMBL1031964,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52740,,2674125,CHEMBL1031142,"Antibacterial activity against Streptococcus pneumoniae HMC 1068 harboring E85K mutation in quinolone-resistant determining regions of GyrA gene, S79Y, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52741,,2674131,CHEMBL1031141,"Antibacterial activity against Streptococcus pneumoniae HMC 1062 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52742,,2674137,CHEMBL1031140,"Antibacterial activity against Streptococcus pneumoniae HMC 4026 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52743,,2674143,CHEMBL1031139,"Antibacterial activity against Streptococcus pneumoniae HMC 2536 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52744,,2674149,CHEMBL1031138,"Antibacterial activity against Streptococcus pneumoniae HMC 2527 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52745,,2674155,CHEMBL1031137,"Antibacterial activity against Streptococcus pneumoniae HMC 1541 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52746,,2674161,CHEMBL1031136,"Antibacterial activity against Streptococcus pneumoniae HMC 1156 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52747,,2674167,CHEMBL1031135,"Antibacterial activity against Streptococcus pneumoniae HMC 1139 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52748,,2674173,CHEMBL1026129,"Antibacterial activity against Streptococcus pneumoniae HMC 1078 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52749,,2674179,CHEMBL1026128,Antibacterial activity against Streptococcus pneumoniae HMC 1077 harboring S81Y and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52750,,2674185,CHEMBL1026127,"Antibacterial activity against Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52751,,2674191,CHEMBL1026126,"Antibacterial activity against Streptococcus pneumoniae HMC 1072 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52752,,2674197,CHEMBL1026125,"Antibacterial activity against Streptococcus pneumoniae HMC 1071 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and S79F, K137N mutation in QRDR of ParC gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52753,,2674203,CHEMBL1026124,"Antibacterial activity against Streptococcus pneumoniae HMC 1059 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460N mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52754,,2674209,CHEMBL1025290,"Antibacterial activity against Streptococcus pneumoniae HMC 1055 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52755,,2674215,CHEMBL1025289,Antibacterial activity against Streptococcus pneumoniae HMC 5041 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52756,,2674221,CHEMBL1025288,"Antibacterial activity against Streptococcus pneumoniae HMC 2538 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin, gatifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52757,,2674227,CHEMBL1025287,"Antibacterial activity against Streptococcus pneumoniae HMC 1150 harboring S81C mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52758,,2674233,CHEMBL1025286,"Antibacterial activity against Streptococcus pneumoniae HMC 1147 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to gemifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52759,,2674239,CHEMBL1025285,"Antibacterial activity against Streptococcus pneumoniae HMC 1146 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and D435N mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52760,,2674245,CHEMBL1025284,"Antibacterial activity against Streptococcus pneumoniae HMC 1076 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52761,,2674251,CHEMBL1025283,"Antibacterial activity against Streptococcus pneumoniae HMC 1073 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52762,,2674257,CHEMBL1025282,"Antibacterial activity against Streptococcus pneumoniae HMC 1070 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52763,,2674263,CHEMBL1025281,"Antibacterial activity against Streptococcus pneumoniae HMC 1066 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52764,,2674269,CHEMBL1025280,"Antibacterial activity against Streptococcus pneumoniae HMC 1060 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52765,,2674928,CHEMBL1025279,"Antibacterial activity against Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52766,,2674934,CHEMBL1031123,"Antibacterial activity against Streptococcus pneumoniae HMC 1151 harboring D83N, K137N mutation in quinolone-resistant determining regions of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52767,,2674940,CHEMBL1031122,"Antibacterial activity against Streptococcus pneumoniae HMC 1149 harboring S81F and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52768,,2674948,CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
52769,,2674957,CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,16.0
52770,,2674966,CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52771,,2674975,CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52772,,2674984,CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
52773,,2674993,CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52774,,2675002,CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
52775,,2675011,CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52776,,2675020,CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
52777,,2675029,CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52778,,2675038,CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
52779,,2675047,CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52780,,2675056,CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
52781,,2675066,CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
52782,,2675072,CHEMBL1026152,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB after 50 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52783,,2675079,CHEMBL1026154,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae HMC 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52784,,2675085,CHEMBL1026155,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52785,,2675090,CHEMBL1026156,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52786,,2675096,CHEMBL1026974,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 41 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52787,,2675102,CHEMBL1026975,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 42 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52788,,2675108,CHEMBL1026976,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene after 22 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52789,,2675114,CHEMBL1026977,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S79Y mutation in quinolone-resistant determining regions of ParC gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52790,,2675120,CHEMBL1026978,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 28 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52791,,2675126,CHEMBL1026979,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 36 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52792,,2675132,CHEMBL1026980,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 49 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52793,,2675138,CHEMBL1026981,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and I460V, D435N mutation in QRDR of ParE gene after 46 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52794,,2675144,CHEMBL1029503,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring I460V mutation in QRDR of ParE gene after 41 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52795,,2675150,CHEMBL1031996,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F, E85K mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 27 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
52796,,2675159,CHEMBL1031999,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 38 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52797,,2675164,CHEMBL1032774,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 44 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52798,,2675172,CHEMBL1032779,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA after 44 passages by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52799,,2675177,CHEMBL1032784,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 after 34 passages by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819149,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52800,,2676303,CHEMBL1054590,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.5
52801,,2676304,CHEMBL1054591,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,1.0
52802,,2676305,CHEMBL1054592,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,1.0
52803,,2677035,CHEMBL1054590,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,1.0
52804,,2677036,CHEMBL1054591,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,1.0
52805,,2677037,CHEMBL1054592,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,1.0
52806,,2677059,CHEMBL1054590,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.125
52807,,2677060,CHEMBL1054591,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2063G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.5
52808,,2677061,CHEMBL1054592,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae harboring A2064G transition in domain V of 23S rRNA isolated from pediatric patients with community-acquired pneumonia after 10 to 14 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151455,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818619,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.5
52809,,2679188,CHEMBL939743,Antibacterial activity against vancomycin-resistant Staphylococcus aureus HIP14300 isolated from patients foot wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
52810,,2679189,CHEMBL941479,Antibacterial activity against Enterococcus faecalis HIP14333 isolated from patients rectum by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
52811,,2679190,CHEMBL941480,Antibacterial activity against vancomycin-resistant Staphylococcus aureus HIP15178 isolated from patients surgical wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
52812,,2679191,CHEMBL945596,Antibacterial activity against Enterococcus faecalis HIP15179 coisolated with vancomycin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
52813,,2679192,CHEMBL952610,Antibacterial activity against vancomycin-resistant Staphylococcus aureus AIS2006032 isolated from patients foot wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
52814,,2679193,CHEMBL940631,Antibacterial activity against Enterococcus faecalis AIS2007003 isolated from patients rectum by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
52815,,2679194,CHEMBL1034671,Antibacterial activity against Enterococcus avium AIS2007004 isolated from patients rectum by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612354,Enterococcus avium,Enterococcus avium,33945.0,,MIC,ug ml-1,UO_0000274,8.0
52816,,2679195,CHEMBL1034672,Antibacterial activity against vancomycin-resistant Staphylococcus aureus AIS2006049 isolated from patients arm wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819723,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
52817,,2680110,CHEMBL1060637,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52818,,2680111,CHEMBL1060638,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
52819,,2680112,CHEMBL1060639,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52820,,2680113,CHEMBL1060640,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52821,,2680114,CHEMBL1060641,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 assessed as mutant prevention concentration after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,0,=,MPC,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MPC,ug ml-1,UO_0000274,2.0
52822,,2680115,CHEMBL1060642,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 assessed as mutant prevention concentration after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,0,=,MPC,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MPC,ug ml-1,UO_0000274,2.0
52823,,2680116,CHEMBL1060643,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as mutant prevention concentration after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MPC,ug ml-1,UO_0000274,4.0
52824,,2680117,CHEMBL1060644,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 ParC Ser79Phe assessed as mutant prevention concentration after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,0,=,MPC,ug ml-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MPC,ug ml-1,UO_0000274,32.0
52825,,2680122,CHEMBL1060645,Ratio of mutant prevention concentration for Streptococcus pneumoniae ATCC 49619 to MIC for Streptococcus pneumoniae ATCC 49619,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
52826,,2680123,CHEMBL1060646,Ratio of mutant prevention concentration for Streptococcus pneumoniae isolate SR-23958 to MIC for Streptococcus pneumoniae isolate SR-23958,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
52827,,2680124,CHEMBL1060647,Ratio of mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134 to MIC for Streptococcus pneumoniae isolate SR-26134,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
52828,,2680125,CHEMBL1061509,Ratio of mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137 to MIC for Streptococcus pneumoniae isolate SR-26137,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,32.0
52829,,2680138,CHEMBL1063306,Antibacterial activity against 80 mg q.d. moxifloxacin-pretreated Streptococcus pneumoniae isolate SR-26134 after 48 hrs of incubation by population analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52830,,2680139,CHEMBL1063307,Antibacterial activity against 200 mg b.i.d. levofloxacin-pretreated Streptococcus pneumoniae isolate SR-26134 after 48 hrs of incubation by population analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52831,,2680140,CHEMBL1063308,Antibacterial activity against 80 mg q.d. moxifloxacin-pretreated Streptococcus pneumoniae isolate SR-26137 after 48 hrs of incubation by population analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52832,,2680141,CHEMBL1063309,Antibacterial activity against 200 mg b.i.d. levofloxacin-pretreated Streptococcus pneumoniae isolate SR-26137 after 48 hrs of incubation by population analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823127,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52833,,2680142,CHEMBL1063310,Ratio of MIC for moxifloxacin-pretreated Streptococcus pneumoniae isolate SR-26134 after 48 hrs to MIC for Streptococcus pneumoniae isolate SR-26134,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
52834,,2680143,CHEMBL1064112,Ratio of MIC for levofloxacin-pretreated Streptococcus pneumoniae isolate SR-26134 after 48 hrs to MIC for Streptococcus pneumoniae isolate SR-26134,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,8.0
52835,,2680150,CHEMBL1064119,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae ATCC 49619",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,26.81,CHEMBL612545,,Unchecked,,,Ratio,,,26.81
52836,,2680152,CHEMBL1064120,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae isolate SR-23958",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,53.63,CHEMBL612545,,Unchecked,,,Ratio,,,53.63
52837,,2680153,CHEMBL1064121,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae isolate SR-26134",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,26.81,CHEMBL612545,,Unchecked,,,Ratio,,,26.81
52838,,2680154,CHEMBL1064122,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae isolate SR-26137",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,26.81,CHEMBL612545,,Unchecked,,,Ratio,,,26.81
52839,,2680160,CHEMBL1064129,"Ratio of Cmax in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae ATCC 49619",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.4,CHEMBL612545,,Unchecked,,,Ratio,,,2.4
52840,,2680161,CHEMBL1064130,"Ratio of Cmax in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae isolate SR-23958",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,4.81,CHEMBL612545,,Unchecked,,,Ratio,,,4.81
52841,,2680162,CHEMBL1064131,"Ratio of Cmax in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae isolate SR-26134",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.4,CHEMBL612545,,Unchecked,,,Ratio,,,2.4
52842,,2680163,CHEMBL1064132,"Ratio of Cmax in human at 200 mg, po administered twice daily to MIC for Streptococcus pneumoniae isolate SR-26137",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,2.4,CHEMBL612545,,Unchecked,,,Ratio,,,2.4
52843,,2680170,CHEMBL1064139,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae ATCC 49619",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,13.41,CHEMBL612545,,Unchecked,,,Ratio,,,13.41
52844,,2680171,CHEMBL1064140,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-23958",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,13.41,CHEMBL612545,,Unchecked,,,Ratio,,,13.41
52845,,2680172,CHEMBL1064141,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,6.7,CHEMBL612545,,Unchecked,,,Ratio,,,6.7
52846,,2680173,CHEMBL1064142,"Ratio of AUC (0 to 24 hrs) in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,0.84,CHEMBL612545,,Unchecked,,,Ratio,,,0.84
52847,,2680180,CHEMBL1057140,"Ratio of Cmax in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae ATCC 49619",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,1.2,CHEMBL612545,,Unchecked,,,Ratio,,,1.2
52848,,2680181,CHEMBL1057141,"Ratio of Cmax in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-23958",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,1.2,CHEMBL612545,,Unchecked,,,Ratio,,,1.2
52849,,2680182,CHEMBL1057142,"Ratio of Cmax in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,0.6,CHEMBL612545,,Unchecked,,,Ratio,,,0.6
52850,,2680183,CHEMBL1057143,"Ratio of Cmax in human at 200 mg, po administered twice daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,=,1,0,=,Ratio,,0.08,CHEMBL612545,,Unchecked,,,Ratio,,,0.08
52851,,2680200,CHEMBL1057159,"Time above the mutant prevention concentration in Streptococcus pneumoniae ATCC 49619 infected human at 200 mg, po administered twice daily after 24 hrs",A,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,823127,=,1,0,=,Activity,%,7.92,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,7.92
52852,,2680201,CHEMBL1057160,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-23958 infected human at 200 mg, po administered twice daily after 24 hrs",A,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,823127,=,1,0,=,Activity,%,7.92,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,7.92
52853,,2680202,CHEMBL1057161,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-26134 infected human at 200 mg, po administered twice daily after 24 hrs",A,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,823127,=,1,0,=,Activity,%,0.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,0.0
52854,,2680203,CHEMBL1057162,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-26137 infected human at 200 mg, po administered twice daily after 24 hrs",A,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,823127,=,1,0,=,Activity,%,0.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,0.0
52855,Active,2680212,CHEMBL1057962,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 assessed as reduction in number of viable cells under condition simulating oral administration of 200 mg twice daily,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52856,Active,2680213,CHEMBL1057963,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 assessed as reduction in number of viable cells under condition simulating oral administration of 200 mg twice daily,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52857,Not Active,2680214,CHEMBL1057964,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as reduction in number of viable cells under condition simulating oral administration of 200 mg twice daily,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52858,Not Active,2680215,CHEMBL1057965,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 assessed as reduction in number of viable cells under condition simulating oral administration of 200 mg twice daily,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52859,Active,2680216,CHEMBL1057966,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as prevention of bacterial regrowth under condition simulating oral administration of 200 mg twice daily after 72 hrs,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52860,Active,2680217,CHEMBL1057967,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 assessed as prevention of bacterial regrowth under condition simulating oral administration of 200 mg twice daily after 72 hrs,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52861,Not Active,2680218,CHEMBL1057968,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as prevention of bacterial regrowth under condition simulating oral administration of 200 mg twice daily after 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52862,Not Active,2680219,CHEMBL1057969,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 assessed as prevention of bacterial regrowth under condition simulating oral administration of 200 mg twice daily after 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,823127,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52863,,2685017,CHEMBL1056341,Antimicrobial activity against Acinetobacter baumannii BM4454 isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823046,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
52864,,2685018,CHEMBL1056342,Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeABC adeIJK double mutant isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823046,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.38
52865,,2685019,CHEMBL1063234,Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823046,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
52866,,2685020,CHEMBL1056343,Antimicrobial activity against Acinetobacter baumannii BM4579 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823046,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.0
52867,,2685021,CHEMBL1056344,Antimicrobial activity against Acinetobacter baumannii BM4651 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823046,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,3.0
52868,,2685022,CHEMBL1063235,Antimicrobial activity against Acinetobacter baumannii BM4579 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823046,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
52869,,2711145,CHEMBL1053371,"Antibacterial activity against Escherichia coli 1608 containing gyrA L83, L87 mutants assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,826417,=,1,0,=,Ratio,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,5.0
52870,,2711151,CHEMBL1053372,"Antibacterial activity against Escherichia coli 1596 containing gyrA L83 and parC I80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,826417,=,1,0,=,Ratio,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,1.0
52871,,2711161,CHEMBL1053374,"Antibacterial activity against Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1596 containing gyrA L83 and parC I80 mutants",F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,826417,=,1,0,=,Ratio,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,9.0
52872,,2711823,CHEMBL1051720,Antimicrobial activity against Proteus mirabilis JIE273 expressing 16S rRNA methyltransferase RmtC,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152992,Antimicrob Agents Chemother,2008.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827178,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,4.0
52873,,2722826,CHEMBL1060034,Free drug level in one-compartment pharmacodynamic system at simulated oral dose regimen of 500 mg in human for 10 days,A,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829533,=,1,0,=,Fu,ug ml-1,3.6,CHEMBL3879801,,NON-PROTEIN TARGET,,,Fu,ug ml-1,UO_0000274,3.6
52874,,2722837,CHEMBL1060025,Stability assessed as degradation half life,P,BAO_0002115,BAO_0000100,small-molecule physicochemical format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,829533,=,1,1,=,T1/2,hr,20.0,CHEMBL2362975,,No relevant target,,,t1/2,hr,UO_0000032,20.0
52875,,2722838,CHEMBL1060026,Antimicrobial activity against Streptococcus pneumoniae Spn-058 by broth macrodilution technique in presence of 5% lysed horse blood,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829533,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52876,,2722839,CHEMBL1060026,Antimicrobial activity against Streptococcus pneumoniae Spn-058 by broth macrodilution technique in presence of 5% lysed horse blood,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829533,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,1.0
52877,,2722844,CHEMBL1060036,Half life in one-compartment pharmacodynamic system administered at simulated oral dose regimen of 500 mg in human for 10 days,A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,829533,=,1,1,=,T1/2,hr,7.0,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,7.0
52878,,2722847,CHEMBL1060027,Antimicrobial activity against Streptococcus pneumoniae Spn-RC2 by broth macrodilution technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829533,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52879,,2722851,CHEMBL1060030,Antimicrobial activity against Streptococcus pneumoniae Spn-058 by agar dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829533,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
52880,,2722852,CHEMBL1060031,Antimicrobial activity against Streptococcus pneumoniae Spn-RC2 by agar dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829533,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52881,Active,2722855,CHEMBL1060040,Antimicrobial activity against Streptococcus pneumoniae Spn-RC2 infected in one-compartment pharmacodynamic system assessed as decrease in bacterial population administered at simulated oral dose regimen of 500 mg in human for 10 days by quantitative culture assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,829533,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52882,Active,2722856,CHEMBL1055146,Antimicrobial activity against Streptococcus pneumoniae Spn-058 infected in one-compartment pharmacodynamic system assessed as decrease in bacterial population administered at simulated at 750 mg dosage regimen every 12 hrs for 10 days by quantitative culture assay,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,829533,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52883,Not Active,2722857,CHEMBL1055148,Antimicrobial activity against Streptococcus pneumoniae Spn-058 infected in one-compartment pharmacodynamic system assessed as regrowth of bacteria administered at simulated at 500 mg QD dosage regimen measured on day 6,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,829533,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52884,Active,2722872,CHEMBL1055147,Antimicrobial activity against Streptococcus pneumoniae Spn-058 infected in one-compartment pharmacodynamic system assessed as reduction in bacterial density administered at simulated at 500 mg QD dosage regimen measured on day 1,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,829533,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52885,Active,2722873,CHEMBL1055156,Antimicrobial activity against Streptococcus pneumoniae Spn-RC2 infected in one-compartment pharmacodynamic system assessed as regrowth of bacteria administered at simulated at 750 mg dosage regimen every 12 hrs measured on day 3,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,829533,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
52886,,2911606,CHEMBL1041241,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
52887,,2911625,CHEMBL1041242,Antibacterial activity against methicillin-resistant Staphylococcus aureus 05-3 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
52888,,2911644,CHEMBL1041243,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
52889,,2911663,CHEMBL1041244,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 05-1 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
52890,,2911682,CHEMBL1041245,Antibacterial activity against Streptococcus pneumoniae 97100 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52891,,2912045,CHEMBL1041246,Antibacterial activity against Streptococcus pyogenes 9619 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,4.0
52892,,2912064,CHEMBL1041247,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
52893,,2912083,CHEMBL1041248,Antibacterial activity against Escherichia coli 26 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
52894,,2912102,CHEMBL1041249,Antibacterial activity against Klebsiella pneumoniae 7 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
52895,,2912121,CHEMBL1041250,Antibacterial activity against Pseudomonas aeruginosa 17 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
52896,,2912140,CHEMBL1041251,Antibacterial activity against Shigella sonnei 51592 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,1.0
52897,,2912159,CHEMBL1041252,Antibacterial activity against Enterobacter cloacae 45301 after 18 to 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847741,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.125
52898,,2912187,CHEMBL1041253,Cytotoxicity against african green monkey Vero cells assessed as cell viability after 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154061,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,847741,>,1,1,>,CC50,nM,1000000.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,uM,UO_0000065,1000.0
52899,,2912373,CHEMBL1048367,Antibacterial activity against Staphylococcus aureus after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154106,Eur J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846644,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
52900,Active,2929312,CHEMBL1053623,Inhibition of penicillin-sensitive Streptococcus pneumoniae R6 PBP2X preincubated for 1 hr before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid,B,BAO_0000375,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155224,J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,851461,,1,0,,Activity,,,CHEMBL1255138,Streptococcus pneumoniae R6,Penicillin-binding protein 2X,171101.0,,Activity,,,
52901,Active,2929315,CHEMBL1053624,Inhibition of penicillin-resistant Streptococcus pneumoniae 5204 PBP2X preincubated for 4 hrs before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid,B,BAO_0000375,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1155224,J Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,851461,,1,0,,Activity,,,CHEMBL6188,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2x,170187.0,,Activity,,,
52902,,2937926,CHEMBL1044147,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154724,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850822,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,microg/ml,UO_0000274,0.12
52903,,2937939,CHEMBL1044148,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154724,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850822,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,microg/ml,UO_0000274,0.5
52904,,2937952,CHEMBL1044149,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1154724,Eur J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850822,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,microg/ml,UO_0000274,0.015
52905,,2993472,CHEMBL1043580,Fraction unbound in human plasma,A,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1156824,J Med Chem,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,863822,=,1,1,=,Fu,,0.75,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,Fu,,,0.75
52906,,3071191,CHEMBL1044210,Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,874704,=,1,0,=,Activity,uM,1.66,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,uM,UO_0000064,1.66
52907,,3071192,CHEMBL1044211,Antibacterial activity against Bacillus subtilis after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,874704,=,1,0,=,Activity,uM,2.21,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Activity,uM,UO_0000064,2.21
52908,,3071193,CHEMBL1044212,Antibacterial activity against Serratia marcescens after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,874704,=,1,0,=,Activity,uM,1.67,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,uM,UO_0000064,1.67
52909,,3071194,CHEMBL1044213,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,874704,=,1,0,=,Activity,uM,1.66,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,uM,UO_0000064,1.66
52910,,3071195,CHEMBL1044214,Antibacterial activity against Escherichia coli after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,874704,=,1,0,=,Activity,uM,0.97,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,uM,UO_0000064,0.97
52911,,3071644,CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
52912,,3071651,CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,>,1,1,>,MIC80,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC80,ug ml-1,UO_0000274,64.0
52913,,3071658,CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,64.0
52914,,3071686,CHEMBL1066703,Inhibition of Staphylococcus aureus wild type DNA topoisomerase 4,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,=,1,1,=,IC50,ug.mL-1,2.67,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,2.67
52915,,3071693,CHEMBL1066706,Inhibition of Staphylococcus aureus wild type DNA gyrase,B,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,1,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,=,1,1,=,IC50,ug.mL-1,9.41,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,ug ml-1,UO_0000274,9.41
52916,,3071701,CHEMBL1066705,Selectivity ratio of IC50 for Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant to IC50 for Staphylococcus aureus wild type DNA topoisomerase 4,B,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,875206,=,1,0,=,Ratio IC50,,21.38,CHEMBL612545,,Unchecked,,,Ratio IC50,,,21.38
52917,,3071705,CHEMBL1066708,Selectivity ratio of IC50 for Staphylococcus aureus DNA gyrase Ser84Leu mutant to IC50 for Staphylococcus aureus wild type DNA gyrase,B,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,875206,>,1,0,>,Ratio IC50,,54.4,CHEMBL612545,,Unchecked,,,Ratio IC50,,,54.4
52918,,3071706,CHEMBL1066704,Inhibition of Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,=,1,1,=,IC50,ug.mL-1,57.1,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,57.1
52919,,3071710,CHEMBL1066707,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1152592,Bioorg Med Chem,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875206,>,1,1,>,IC50,ug.mL-1,512.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,IC50,ug ml-1,UO_0000274,512.0
52920,,3383891,CHEMBL1220798,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,930660,=,1,1,=,IZ,mm,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,0.0
52921,,3383892,CHEMBL1220799,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,930660,=,1,1,=,IZ,mm,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,0.0
52922,,3383893,CHEMBL1220800,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene at 10 ug by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,930660,=,1,1,=,IZ,mm,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,0.0
52923,,3384916,CHEMBL1220655,Apparent permeability across basolateral to apical side in human Calu3 cells,A,BAO_0002808,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,929569,=,1,0,=,Papp,10'-6 cm/s,6.2,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,6.2
52924,,3384922,CHEMBL1220656,Efflux ratio of apparent permeability across basolateral to apical side over apical to basolateral side in human Calu3 cells,A,BAO_0000193,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,929569,=,1,0,=,Ratio,,2.6,CHEMBL612558,,ADMET,,,Ratio,,,2.6
52925,,3384928,CHEMBL1220657,Apparent permeability across apical to basolateral side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,BAO_0002808,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,929569,=,1,0,=,Papp,10'-6 cm/s,4.2,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,4.2
52926,,3384934,CHEMBL1220658,Apparent permeability across basolateral to apical side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,BAO_0002808,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,929569,=,1,0,=,Papp,10'-6 cm/s,4.3,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,4.3
52927,,3384940,CHEMBL1220659,Efflux ratio of apparent permeability across basolateral to apical side over apical to basolateral side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,BAO_0000193,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,929569,=,1,0,=,Ratio,,1.0,CHEMBL612558,,ADMET,,,Ratio,,,1.0
52928,,3385299,CHEMBL1221038,Antibacterial activity against Stenotrophomonas maltophilia D457 containing chromosomally encoded Smqnr gene by epsilon test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930145,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,0.5
52929,,3385300,CHEMBL1221039,Antibacterial activity against Stenotrophomonas maltophilia MBS108 containing both chromosomally and plasmid encoded Smqnr gene by epsilon test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930145,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,1.0
52930,,3385301,CHEMBL1221040,Antibacterial activity against Stenotrophomonas maltophilia MBS109 containing chromosomally encoded Smqnr gene by epsilon test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930145,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,0.5
52931,,3385302,CHEMBL1221041,Antibacterial activity against Stenotrophomonas maltophilia MBS82 deficient in Smqnr gene by epsilon test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930145,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,0.25
52932,,3385303,CHEMBL1221042,Antibacterial activity against Stenotrophomonas maltophilia MBS101 containing plasmid encoded Smqnr gene by epsilon test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930145,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,1.0
52933,,3385304,CHEMBL1221043,Antibacterial activity against Stenotrophomonas maltophilia MBS100 deficient in Smqnr gene by epsilon test,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930145,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,mg/L,UO_0000274,0.25
52934,,3385339,CHEMBL1220253,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52145R assessed as growth inhibition by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212756,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930250,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.09
52935,,3385352,CHEMBL1220254,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrB containing isogenic acrB knockout assessed as growth inhibition by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212756,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930250,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.006
52936,,3385365,CHEMBL1220255,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrR containing isogenic acrR knockout assessed as growth inhibition by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212756,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930250,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.19
52937,,3385933,CHEMBL1220654,Apparent permeability across apical to basolateral side in human Calu3 cells,A,BAO_0002808,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,929569,=,1,0,=,Papp,10'-6 cm/s,2.4,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,2.4
52938,,3386106,CHEMBL1216044,Antimicrobial activity against Haemophilus influenzae isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.016
52939,,3386107,CHEMBL1216044,Antimicrobial activity against Haemophilus influenzae isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC90,ug.mL-1,0.031,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.031
52940,,3386108,CHEMBL1217979,"Antimicrobial activity against beta-lactamase-negative, ampicillin-sensitive Haemophilus influenzae by broth microdilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.016
52941,,3386109,CHEMBL1217979,"Antimicrobial activity against beta-lactamase-negative, ampicillin-sensitive Haemophilus influenzae by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC90,ug.mL-1,0.031,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.031
52942,,3386110,CHEMBL1217980,"Antimicrobial activity against Beta-lactamase-positive, ampicillin-resistant Haemophilus influenzae by broth microdilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.016
52943,,3386111,CHEMBL1217980,"Antimicrobial activity against Beta-lactamase-positive, ampicillin-resistant Haemophilus influenzae by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC90,ug.mL-1,0.031,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.031
52944,,3386112,CHEMBL1217981,"Antimicrobial activity against Beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae by broth microdilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.016
52945,,3386113,CHEMBL1217981,"Antimicrobial activity against Beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC90,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.016
52946,,3386114,CHEMBL1217982,"Antimicrobial activity against Beta-lactamase-positive, ampicillin-cluvulanate-resistant Haemophilus influenzae by broth microdilution method",F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.016
52947,,3386115,CHEMBL1217982,"Antimicrobial activity against Beta-lactamase-positive, ampicillin-cluvulanate-resistant Haemophilus influenzae by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212764,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929689,=,1,1,=,MIC90,ug.mL-1,0.031,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.031
52948,,3388548,CHEMBL1216185,Antimicrobial activity against drug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.064
52949,,3388556,CHEMBL1216186,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
52950,,3388564,CHEMBL1216187,Antimicrobial activity against imipenem resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
52951,,3388572,CHEMBL1216188,Antimicrobial activity against Ceftazidime resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.064
52952,,3388580,CHEMBL1216189,Antimicrobial activity against piperacillin-tazobactam resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.064
52953,,3388588,CHEMBL1216190,Antimicrobial activity against tobramycin resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
52954,,3388596,CHEMBL1216185,Antimicrobial activity against drug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,8.0
52955,,3388604,CHEMBL1216186,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,32.0
52956,,3388612,CHEMBL1216187,Antimicrobial activity against imipenem resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,16.0
52957,,3388620,CHEMBL1216188,Antimicrobial activity against Ceftazidime resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,4.0
52958,,3388628,CHEMBL1216189,Antimicrobial activity against piperacillin-tazobactam resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,4.0
52959,,3388636,CHEMBL1216190,Antimicrobial activity against tobramycin resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,32.0
52960,,3388652,CHEMBL1216186,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,128.0
52961,,3388660,CHEMBL1216187,Antimicrobial activity against imipenem resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,64.0
52962,,3388668,CHEMBL1216188,Antimicrobial activity against Ceftazidime resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,64.0
52963,,3388676,CHEMBL1216189,Antimicrobial activity against piperacillin-tazobactam resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,64.0
52964,,3388684,CHEMBL1216190,Antimicrobial activity against tobramycin resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,128.0
52965,,3389166,CHEMBL1216577,Antibacterial activity against azide-resistant Escherichia coli J53 SXT1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212795,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930158,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
52966,,3389174,CHEMBL1216578,Antibacterial activity against azide-resistant Escherichia coli J53 SXT2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212795,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930158,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
52967,,3389182,CHEMBL1216579,Antibacterial activity against azide-resistant Escherichia coli J53 TET1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212795,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930158,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
52968,,3389190,CHEMBL1216580,Antibacterial activity against azide-resistant Escherichia coli J53 TET2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212795,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930158,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
52969,,3389200,CHEMBL1216582,Antibacterial activity against azide-resistant Escherichia coli J53 containing plasmid pQE60,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212795,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930158,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
52970,,3389202,CHEMBL1216583,Antibacterial activity against azide resistant Escherichia coli J53 transformed with pQE60-qnrVC3 gene Vibrio cholerae 59 strain,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212795,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930158,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
52971,,3389315,CHEMBL1216185,Antimicrobial activity against drug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929842,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,64.0
52972,,3389538,CHEMBL1216831,Antibacterial activity against Streptococcus pneumoniae 3321 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,32.0
52973,,3389541,CHEMBL1216830,Antibacterial activity against Streptococcus pneumoniae 1151 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,32.0
52974,,3389544,CHEMBL1216829,Antibacterial activity against Streptococcus pneumoniae 1149 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,>,1,0,>,Activity,ug ml-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,64.0
52975,,3389547,CHEMBL1216828,Antibacterial activity against Streptococcus pneumoniae 1072 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,256.0
52976,,3389550,CHEMBL1216827,Antibacterial activity against Streptococcus pneumoniae 1135 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
52977,,3389553,CHEMBL1216826,Antibacterial activity against Streptococcus pneumoniae 1065 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52978,,3389556,CHEMBL1216825,Antibacterial activity against Streptococcus pneumoniae 1058 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52979,,3389559,CHEMBL1216824,Antibacterial activity against Streptococcus pneumoniae 3321 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
52980,,3389562,CHEMBL1216823,Antibacterial activity against Streptococcus pneumoniae 1151 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
52981,,3389565,CHEMBL1216822,Antibacterial activity against Streptococcus pneumoniae 1149 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
52982,,3389568,CHEMBL1216821,Antibacterial activity against Streptococcus pneumoniae 1072 by standard agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
52983,,3389570,CHEMBL1216820,Ratio of 90% mutant prevention concentration to MIC90 in Streptococcus pneumoniae ATCC 49619,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,930685,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
52984,,3389573,CHEMBL1216819,Ratio of 50% mutant prevention concentration to MIC50 in Streptococcus pneumoniae ATCC 49619,F,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,930685,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
52985,,3389576,CHEMBL1216818,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as 90% mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,64.0
52986,,3389579,CHEMBL1216817,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as 50% mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,4.0
52987,,3389582,CHEMBL1216816,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,32.0
52988,,3389585,CHEMBL1216816,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
52989,,3389589,CHEMBL1216832,Antibacterial activity against Streptococcus pneumoniae 1058 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,64.0
52990,,3389592,CHEMBL1216833,Antibacterial activity against Streptococcus pneumoniae 1065 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,32.0
52991,,3389595,CHEMBL1216834,Antibacterial activity against Streptococcus pneumoniae 1135 assessed as mutant prevention concentration by standard agar dilution method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930685,=,1,0,=,Activity,ug ml-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,128.0
52992,,3397339,CHEMBL1220709,Antibacterial activity against Pseudomonas aeruginosa PA5026 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52993,,3397340,CHEMBL1220711,Antibacterial activity against Pseudomonas aeruginosa PA861 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52994,,3397341,CHEMBL1220710,Antibacterial activity against Pseudomonas aeruginosa PA876 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52995,,3397342,CHEMBL1220713,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52996,,3397343,CHEMBL1220714,Antibacterial activity against Pseudomonas aeruginosa PA1054 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52997,,3397344,CHEMBL1220716,Antibacterial activity against Pseudomonas aeruginosa PA1022 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52998,,3397345,CHEMBL1220715,Antibacterial activity against Pseudomonas aeruginosa PA899 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
52999,,3397346,CHEMBL1220717,Antibacterial activity against Pseudomonas aeruginosa PA1042 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,930452,<=,1,1,<=,TIME,hr,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.5
